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The basic tenets of gametogenesis are conserved among metazoans. After lineage 
commitment, germ cells proliferate, complete meiosis, and then differentiate into gametes 
capable of fertilization. In the mouse, spermatogenesis begins at approximately postnatal day (P) 
3-4, as prospermatogonia transition into distinct populations of spermatogonia. Some 
prospermatogonia become spermatogonial stem cells (SSCs) that provide a consistent source of 
gametes throughout the male reproductive lifespan. The remaining prospermatogonia proliferate 
and directly differentiate (without going through an SSC stage) in response to retinoic acid (RA) 
to eventually enter meiosis at P10. The pathways and cellular mechanisms that direct this critical 
cell fate decision are poorly defined. This dissertation summarizes the results of an examination 
of the cellular and molecular changes that occur downstream of RA signaling that direct 
prospermatogonia at P0-2 to transition to differentiating spermatogonia at P3-4. The results 
support a novel mechanism by which RA directs spermatogonial differentiation during 
spermatogenesis.  
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CHAPTER I:  INTRODUCTION 
 
A. Primordial germ cell (PGC) Development 
Germ cells are one of the earliest cell lineages specified in the embryo. They are initially 
termed primordial germ cells (PGCs), and their sole developmental fate is to form gametes. 
However, in vitro or under pathological conditions, PGCs can demonstrate the characteristics of 
pluripotent stem cells [1]. In the mouse, PGCs arise from the proximal epiblast and are 
detectable as early as embryonic day (E) 6.25 as a small population of PRDM1+ (also called 
BLIMP1) cells [2]. These cells respond to diffusible signals including BMP4 and BMP8B from 
the adjacent extraembryonic ectoderm and BMP2 from visceral endoderm to suppress the 
somatic lineage and retain expression of protein markers associated with pluripotency ([3-5], 
reviewed by [6]). There are approximately 40 founder PGCs marked by the expression of 
DPPA3 that occupy the proximal epiblast [7, 8]. These cells rapidly proliferate and migrate into 
extra-embryonic mesoderm at the base of the allantois, where they are identified as a cluster of 
alkaline phosphatase positive (ALPL+) cells by E7.2-E7.75. Under the guidance of several 
signals, including KIT/KITL (also known as stem cell factor) [9, 10], CXCL12/CXCR4 [11], 
FOXC1 [12], LHX1 [13], WNT5A [14], and ROR2 [15], PGCs traverse the hindgut and dorsal 
body wall from E9.0-E9.5 and E10.0-E10.5, respectively, to colonize the genital ridges from 
E10.5-E12.5 [16-18]. After their arrival at the gonad, PGCs closely associate with the somatic 
cells of the developing gonad [19]. These multipotent supporting cells originate from the 
coelomic epithelium and invade the genital ridges from E11.2-E11.4 and will differentiate into 
either Sertoli cells or granulosa cells in XY or XX embryos, respectively [20].  
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B. Sex Determination  
Genetic sex is established at fertilization, but through E11 the gonad is described as 
bipotential (or indifferent). This means that, despite having a genotypic sex of XX or XY, the 
male and female gonads are phenotypically indistinguishable and can be induced to form either a 
testis or an ovary. Phenotypic sex determination initiates at E11.5 with the expression of the gene 
sex-determining region of the Y chromosome (Sry) in Sertoli cells [21-23]. SRY induces a 
cascade of molecular events that begin with the expression of Sox9, which in turn directs 
masculinization of the XY gonad [24]. Both Sry and Sox9 are necessary and sufficient to induce 
the XY gonad to develop as a testis. This is evident from experiments in which ectopic 
expression of Sry or Sox9 resulted in complete female-to-male sex reversal of the XX gonad [21, 
25]. Conversely, loss of either Sry or Sox9 in an XY gonad leads to its development as an ovary 
[26, 27], demonstrating that their expression is required to overcome the default pathway of 
female development. In the XX gonad, loss of genes required for ovary development, such as 
Wnt4 or its downstream effector Ctnnb1 (also called β-catenin) only causes partial ovary-to-testis 
sex reversal [28, 29]. Somewhat surprisingly, testis development can occur independently of 
germ cells. Studies have demonstrated that Sertoli and Leydig cell development, as well as 
formation of the seminiferous cords, occur normally in the absence of germ cells [30, 31]. Taken 
together, these results support the notion that formation of the ovary is the default developmental 
pathway and formation of a testis requires instructive cues to deviate from this pathway. 
However, this is not to suggest that female development occurs independent of activation of 
important cellular pathways, but that an ovary and associated female structures will form in the 
absence of SRY. 
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C. Fetal Testis Development 
 Prior to sex determination, PGCs are not committed to either a male or female 
developmental fate. Rather, their fate is dependent on the environment provided by the gonadal 
somatic cells. After sex determination, female germ cells become oogonia and male germ cells 
become prospermatogonia (termed type M prospermatogonia) (reviewed by [32]). By E13.5, 
each has dramatically developed toward their sex-specific fates. In the female, oogonia enter 
meiosis as oocytes at approximately E13.5, which progress to the diplotene stage of meiosis I, 
before arresting around birth. Oocytes then resume and complete meiosis I prior to ovulation. In 
stark contrast, prospermatogonia briefly proliferate in the testis until E14.5 and then enter an 
extended period of quiescence until postnatal day (P) 0-1, and they do not enter meiosis until 
approximately P10 [33, 34]. 
The testis undergoes dramatic morphological changes following sex determination. 
Sertoli cells surround the prospermatogonia, leading to the formation of approximately 12 testis 
cords. The testis cords are connected at each end to the rete testis and are initially short and 
straight. However, as Sertoli cells proliferate, the cords fill the testis and bend, forming the 
coiled pattern observed in the adult [35, 36]. Testis cord development is not dependent on germ 
cells, as they form normally in mutant mice lacking germ cells [30]. When Sertoli cells are 
cultured in the presence of an extracellular matrix, they condense into primitive testis cord 
structures, suggesting that initial testis cord formation is solely due to Sertoli cell interactions 
[37]. Peritubular myoid cells are required for completion of the testis cord architecture. 
Interactions between Sertoli and peritubular myoid cells form the basement membrane, which is 
required for the function and integrity of the testis cords [38, 39]. In addition, formation of testis-
specific vasculature is required for the formation and function of the testis cords. After sex 
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determination, the vasculature of the adjacent mesonephric kidney degenerates and endothelial 
cells from that structure migrate into the testis to form the coelomic artery [40, 41], which runs 
the length of the testis at its antimesonephric margin. Testis cords do not form if the 
mesonephros is removed or a semipermeable membrane blocks endothelial cell migration [42, 
43]. Subsequent vascular growth from the coelomic artery is required for the formation of the 
testis cords. Taken together, these studies demonstrate that testis cord formation requires 
cooperation between Sertoli and peritubular myoid cells that develop within the genital ridges 
and the endothelial cells that migrate into the testis from the mesonephros.  
Sertoli cells also direct formation of fetal Leydig cells. At E11.5, Sertoli cells begin to 
secrete desert hedgehog (DHH) and platelet-derived growth factor alpha (PDGFA) that direct 
interstitial cells to develop into fetal Leydig cells [44, 45]. Over the next few days, fetal Leydig 
cells proliferate and the population significantly increases. The main function of these cells is to 
produce testosterone, which is crucial for the development of male secondary sex characteristics 
[46, 47]. Therefore, the two main functions of the testis (gamete and androgen production) are 
established by E13.5. 
Although the fetal gonad is preprogrammed to develop into an ovary, fetal germ cells 
require an instructive cue to enter meiosis as oocytes [48]. In the 1970s, Byskov and Saxen 
reported that fetal oogonia enter meiosis in response to a “meiosis inducing substance” [49]. In 
contrast, fetal testes were thought to produce a “meiosis inhibiting substance” which prevents 
prospermatogonia from entering meiosis. Further investigations found that germ cells from either 
sex will enter meiosis if transplanted into extra-gonadal tissues such as the adrenal glands or 
lungs, or if they are cultured in media containing serum [50-52]. These observations led to the 
opposing view that fetal meiotic entry is intrinsically preprogrammed for both male and female 
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germ cells [53]. However, two concurrent paradigm-shifting reports from the laboratories of 
Peter Koopman and David Page revealed that retinoic acid (RA) is the meiosis inducing 
substance in the fetal ovary [54, 55]. It was later shown that the cytochrome P450 enzyme 
CYP26B1 prevents meiosis in the fetal testis by actively degrading RA [56-58]. Therefore, RA is 
the meiosis-inducing substance, and in the fetal testis CYP26B1 is the meiosis-inhibiting 
substance. 
The gonadal somatic environment controls germ cell meiotic initiation. At E12.5, both 
XX and XY gonads express CYP26B1 [54, 55]. However, at E13.5 the ovary no longer 
expresses CYP26B1, thus allowing RA from the adjacent mesonephros to diffuse into the ovary 
in a cranial-caudal fashion. RA signals oogonia to differentiate and enter meiosis, driving the 
expression of the meiotic markers stimulated by retinoic acid gene 8 (Stra8), REC8 meiotic 
recombination protein (Rec8), synaptonemal complex protein 3 (Sycp3), and DMC1 dosage 
suppressor of mck1 homolog, meiosis-specific homologous recombination (Dmc1) [59-63]. 
Conversely, Sertoli cells continue to produce CYP26B1 in the male throughout the remainder of 
fetal development. As a result, fetal prospermatogonia do not enter meiosis and do not express 
RA-dependent meiotic markers such as STRA8. However, if CYP26B1 activity is lost, such as 
when inhibited by the drug ketoconazole or when Cyp26b1 is conditionally deleted in fetal 
Sertoli cells, prospermatogonia rapidly enter meiosis, as evidenced by premature chromatin 
condensation and the precocious expression of STRA8, SYCP3, and DMC1 [54, 56, 57]. These 
fetal prospermatogonia appear to progress to the pachytene stage of meiosis before dying by 
apoptosis [56, 57]. This demonstrates that fetal prospermatogonia can respond to RA, although 
they are unable to progress through meiosis. 
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D. Postnatal Testis Development 
 By E14.5, prospermatogonia stop dividing and become quiescent (called type T1 
prospermatogonia). It is during this period of quiescence that prospermatogonia acquire male-
specific patterns of DNA methylation, which is mostly complete by E18.5 (reviewed by [64]). At 
birth, prospermatogonia remain mitotically quiescent and are located in the center of the 
seminiferous cords [65, 66] (Figure 1.1). By P1-2, prospermatogonia reenter the cell cycle (now 
called type T2 prospermatogonia) and migrate to the periphery of the seminiferous cords. 
Completion of both events is apparently required for their survival, as cells that fail to reach the 
basement membrane degenerate [67]. Upon their arrival at the basement membrane, 
prospermatogonia become flanked by Sertoli cells within the cord and peritubular myoid cells 
outside of the cord. Subtle morphological differences in chromatin appearance have been used to 
propose that the prospermatogonial population in the neonatal testis is heterogeneous [68, 69]. 
Some neonatal prospermatogonia reside in the center of the testis cords, and have round tightly 
packed nucleoli, which become irregularly shaped and less tightly packed as prospermatogonia 
migrate to the periphery of the cord. As prospermatogonia migrate toward the periphery, they 
extend cytoplasmic projections, which are not evident once they reach the periphery. However, it 
is unknown whether these morphological changes reflect normal variability or progression 
through specific stages of development. There are currently no reports of differentially expressed 
protein or RNA markers correlated with these morphological differences that might suggest 
functional differences within the neonatal prospermatogonial population.  
In the mouse, spermatogenesis initiates early in neonatal development. In the neonatal 
testis, prospermatogonia have transitioned to spermatogonia by P3-4. This neonatal 
spermatogonial population is heterogeneous, with both type A undifferentiated spermatogonia 
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(Aundiff) [spermatogonial stem cells (SSCs) and progenitor spermatogonia] and type A 
differentiated spermatogonia (Adiff) (Figure 1.2). This first cohort of Adiff spermatogonia develop 
into the first sperm during what is termed the “the first wave of spermatogenesis” [68-72]. These 
first Adiff spermatogonia apparently arise directly from prospermatogonia without transitioning 
from SSCs or Aundiff progenitors [73]. Subsequent waves of spermatogenesis are then maintained 
by spermatogonia that arise from SSCs. 
Multiple lines of evidence suggest that functional differences exist between neonatal and 
adult spermatogonia. For example, spermatogonial differentiation proceeds faster during the first 
wave than in subsequent waves [74]. Following their differentiation at P3-4, neonatal 
spermatogonia enter meiosis 7.42 days later, as opposed to the 8.6 days it takes for 
spermatogonia in the adult mouse. While the exact reason(s) for this shortened period of 
differentiation are unknown, it has been suggested that neonatal spermatogonia skip the A1 step 
and transition directly to type A2 spermatogonia [68, 74]. Another possibility is that the cell 
cycle times are shorter, which may in part be due to the increased temperature (37oC) in the 
neonatal and juvenile testis versus the adult testes (33oC). This is due to the fact that the neonal 
and juvenile testes have not yet descended from the abdomen into the scrotum [75].   
The most widely accepted current model posits that the majority of SSCs are present as 
single cells, which are denoted Asingle, or As [76-78]. If the daughter cells of an SSC division are 
destined to proliferate and differentiate, they retain an approximately 1 µm tubular connection 
termed an intercellular bridge resulting from incomplete cytokinesis [79, 80]. Although the 
function of these bridges is unknown, they allow sharing of small molecules. This likely aids in 
synchronization of subsequent divisions, and may also provide for the sharing of essential X-
linked gene products between adjacent X- and Y-bearing haploid postmeiotic spermatids later in 
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spermatogenesis [81]. Spermatogonia connected by an intercellular bridge are termed Apaired 
(Apr) spermatogonia. They continue to divide and form progressively longer interconnected 
chains of up to 32 cells termed Aaligned (Aal) spermatogonia. These transit-amplifying divisions 
dramatically increase the number of spermatogonia. Although As, Apr, and Aal spermatogonia are 
characterized as “undifferentiated”, evidence supports a diminution of stem cell capacity with 
increased chain length (reviewed by [82]). 
 The commitment to enter meiosis is made with the transition of Aundiff spermatogonia (Apr 
or Aal) into differentiating spermatogonia (type A1). This occurs in response to retinoic acid (RA) 
exposure, which will be discussed in detail below. The first differentiating spermatogonia are 
termed type A1, and these cells undergo 5 divisions to form A2, A3, A4, intermediate (In), and 
finally type B spermatogonia before becoming preleptotene spermatocytes (reviewed by [82]). 
The accurate identification of spermatogonial subtypes relies on characteristic differences in 
nuclear shape and diameter as well as heterochromatin appearance in paraffin-embedded testis 
sections carefully prepared with certain fixatives (e.g. 5% glutaraldehyde or Bouin’s).  In the 
adult testis, identification is aided by the fact that germ cells are present in defined stages of the 
seminiferous epithelium [69, 83, 84]. Neonatal testes lack clearly defined epithelial stages, 
although there have been discussions that the appearance of preleptotene spermatocytes in some 
seminiferous cords at approximately P8 can be used to mark them as stage VII-VIII, as in the 
adult. However, the discrimination between spermatogonial cell types based on morphology is 
difficult to impossible [68, 74]. The topological arrangement of As, Apr, and Aal spermatogonia 
can be visualized in whole mounts of seminiferous cords or tubules using immunofluorescent 
antibody staining. For Adiff subtypes (A1, A2, A3, or A4), there are currently no distinguishing 
protein markers, and no reliable way to distinguish them based on morphology alone, as they are 
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very similar in size and appearance, and the differences in chromatin appearance are both subtle 
and quite variable.    
A number of characteristic proteins have been identified that are detectable solely in 
Aundiff spermatogonia in the adult testis, including ZBTB16/(also called PLZF) [85], CDH1 [86], 
GFRA1, RET [87], ID4 [88], LIN28A [89], and NANOS2 and NANOS3 [90]. In contrast, KIT 
and STRA8 are the only two markers currently detectable solely in differentiating spermatogonia 
[91, 92]. Other markers have increased protein levels in differentiating spermatogonia, including 
RHOX13 [93], SOHLH1, and SOHLH2 [94]. While the above markers are restricted to either 
Aundiff or Adiff spermatogonia in the adult testis, this is largely not true in the neonatal testis. We 
recently reported that markers of Aundiff spermatogonia colocalize with markers of Adiff 
spermatogonia in the neonatal testis, with GFRA1 and RET being notable exceptions [95]. If 
neonatal prospermatogonia are administered an exogenous bolus of RA they will initially express 
differentiation markers. However, as RA levels fall (likely through degradation by CYP26A1) 
spermatogonia apparently revert back to an undifferentiated state [96, 97]. This suggests that 
spermatogonial differentiation occurs gradually in prospermatogonia and spermatogonia in the 
neonatal testis, and that these fates are more clearly established in the juvenile and adult. 
 
E. Control of Spermatogonial Differentiation 
Multicellular organisms contain a wide variety of specialized cell types that originate 
from less specialized cells by differentiation, a progression of specific changes that prepare them 
for their ultimate function. Most specialized cells have a finite lifespan, and therefore must be 
periodically replaced by a population of unipotent or multipotent adult stem cells. These stem 
cells balance self-renewal with the production of progenitor cells that proliferate to amplify their 
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numbers before committing to a specific cell fate, and these systems are found throughout the 
body. In bone marrow, the consistent production of nearly a trillion blood cells daily is managed 
by a comparatively small population of hematopoietic stem cells (HSCs), whose progenitors 
follow unique programs of differentiation to become megakaryocytes, erythrocytes, or 
leukocytes [98, 99].  
The mammalian testis is also a stem cell-based system. Each adult mouse testis contains 
approximately 3,000 unipotent SSCs that produce undifferentiated progenitor spermatogonia that 
amplify before entering meiosis [100]. The human SSC population is responsible for the 
production of approximately 90 million sperm each day throughout the male reproductive 
lifespan, which can span 7 decades [101]. The balance between stem cell self-renewal and 
cellular differentiation is crucial for the reproductive health of the male. Insufficient or excessive 
differentiation can result in reduced or lost sperm production (known by physicians as non-
obstructive oligo- or azoospermia), which are leading causes of male infertility. Currently, 10% 
of couples in the United States are infertile and 50% of these cases are attributed to the male 
(reviewed by [102]. Semen quality (including sperm counts) has been decreasing steadily in 
western societies over the past 40 years with an unclear etiology [103].  
Another important reason to understand the process that regulates spermatogonial 
differentiation is that PGCs and spermatogonia that deviate from normal developmental 
pathways can transform into carcinoma in situ, the precursor lesion for most forms of testicular 
cancer [104, 105], which, is the most common form of cancer in young men (reviewed by [102]). 
Clearly, a balance between self-renewal and differentiation is required for efficient sperm 
production over the lifetime of the male, yet we understand relatively little of the molecular and 
cellular processes that govern spermatogonial fate determination.  
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F. Glial Cell Derived Neurotrophic Factor (GDNF) and RA Signaling 
 Tissue homeostasis is maintained in many epithelial tissues that have a high rate of 
turnover by a balance between stem cell self-renewal and differentiation. In the testis, two of the 
key signals that direct this balance are GDNF and RA. GDNF is required for SSC maintenance 
and is produced by Sertoli cells and peritubular myoid cells, two cell types that compose the 
putative SSC niche [106, 107]. GDNF signals in spermatogonia by binding to GFRA1 [108], 
which then recruits the co-receptor RET [109]. A key role for GDNF in SSCs is to induce the 
expression of a number of transcription factors that direct gene expression changes responsible 
for maintaining the undifferentiated state. Gdnf heterozygous mice demonstrate a 
haploinsufficiency phenotype. Spermatogenesis initially proceeds normally, but as the mice age 
the SSC pool is depleted, eventually causing “Sertoli cell-only” tubules [110]. Conversely, 
overexpressing GDNF blocks spermatogonial differentiation, and this eventually leads to the 
formation of germ cell tumors that consist of undifferentiated spermatogonia. Clearly, careful 
regulation of GDNF levels is required for efficient spermatogenesis. Increased levels of GDNF 
shift the balance towards insufficient spermatogonial differentiation, while low GDNF levels 
prevent SSC self-renewal. Another important function of GDNF and its receptors is to activate 
the PI3K-AKT and the MAP2K7-MAPK1 (also called MEK-ERK) signaling networks [111]. 
Activation of these pathways is thought to be a primary mechanism by which GDNF promotes 
SSC survival and self-renewal. However, substantial work needs to be done to fully define the 
complex mechanisms that control SSC self-renewal and the cellular decision to transition to 
progenitors. 
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It has been known for 90 years that vitamin A is essential for male fertility, as vitamin A 
deficiency (VAD) results in blocked spermatogonial differentiation [112-114]. This is shown by 
experimental approaches in which RA levels are dramatically reduced, either by feeding mice a 
VAD diet or the retinaldehyde dehydrogenase inhibitor WIN 18,446. Either treatment reduces 
RA levels dramatically, which causes a reversible arrest in spermatogonial differentiation at the 
Aal-A1 transition [114-117]. Therefore, it is clear that a primary role for RA in the testis is 
directing spermatogonial differentiation, although the mechanisms involved are not clear. 
Vitamin A is obtained through the diet, as preformed vitamin A and as provitamin A carotenoids 
(reviewed by [118]). Once absorbed, it is stored in the liver and delivered as circulating retinol to 
target tissues, where it is converted into RA. RA is transported poorly in the bloodstream, and 
therefore less than 1% of testicular RA originates from circulation [119]. The levels of RA are 
maintained within tissues by regulating its synthesis, reception, storage, transport, and 
degradation [116, 120, 121]. RA signaling usually occurs in a paracrine fashion; one cell controls 
the production and metabolism of RA, and adjacent cells are the targets of RA action (reviewed 
by [122]). The first step of RA synthesis is to oxidize retinol to retinaldehyde, which is 
accomplished by several alcohol and retinol dehydrogenases. Aldehyde dehydrogenases 
(ALDH1A1, ALDH1A2, and ALDH1A3) are believed to be the primary producers of RA and 
function to catalyze the oxidation of retinaldehyde to RA [123-125]. ALDH1A1/2 are expressed 
in the testis [126, 127]. Inhibition of ALDH1A1 and ALDH1A2 with the aldehyde 
dehydrogenase inhibitor WIN 18,446 causes a 90% reduction in testicular RA levels [128]. 
However, ALDH1A1 is dispensable for male fertility [129] and therefore the majority of 
testicular RA is thought to be produced by ALDH1A2 [126, 128]. Multiple cell types produce 
testicular RA in the adult. However, Sertoli cells appear to be the sole RA producers in the 
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neonatal testis. The seminiferous epithelium only contains Sertoli cells and undifferentiated 
spermatogonia when Aldh1a1-3 is conditionally deleted in Sertoli cells [130]. However, 
preleptotene and pachytene spermatocytes express ALDH1A2, and RA produced by these cell 
types appears to be sufficient to maintain spermatogenesis independent of RA produced by 
Sertoli cells. 
As mentioned previously, fetal prospermatogonia are protected from RA exposure by the 
action of CYP26B1 [54, 55, 57], allowing them to remain quiescent until after birth [65, 66]. At 
P3-4, a subset of spermatogonia becomes exposed to RA (as evidenced by induction of STRA8). 
This implies that either CYP26B1 activity adjacent to these select spermatogonia is reduced or 
lost and/or that RA is synthesized in discrete portions of the testis tubules, although this has not 
been shown experimentally.  
An alternative mechanism to control a cell’s ability to respond to RA is by regulating the 
expression of the RA receptors. RA is a lipid-soluble molecule, and enters the cell to bind with 
high affinity to its cognate receptors. The RA receptors (RARs) are classified as type II nuclear 
receptors. There are three retinoic acid receptor subtypes (RARA, RARB, and RARG), and each 
is capable of heterodimerizing with a retinoid X receptor subtype (RXRA, RXRB, or RXRG). 
Most of the physiological responses to RA follow binding to RARs or RXRs (reviewed by 
[131]). The RAR subtypes are detectable in distinct cell types in the testis: RARB is 
undetectable, RARA is present in Sertoli cells, and RARG is readily detectable in differentiating 
spermatogonia [132]. Therefore, it is logical to assume that RA signaling through RARG has a 
direct effect on spermatogonial differentiation, while signaling through RARA might have an 
indirect effect via Sertoli cells. To address their respective roles in the testis, conventional as 
well as germ and Sertoli cell conditional knockout (KO) mice have been generated for each of 
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the Rar subtypes. Rarb-null mice are viable and fertile, with no apparent defects [133]. In 
contrast, both Rara-null and Rarg-null mice exhibit a number of spermatogenic defects, although 
spermatogonial differentiation proceeds fairly normally, at least through 20 weeks of age in lines 
of KO mice [134, 135]. Conventional and Sertoli cell conditional Rara-null mice have similar 
phenotypes, supporting the prediction that RARA’s major reproductive function is performed in 
Sertoli cells [136]. However, when SSCs from conventional Rara-null mice were transplanted 
into wild type recipient testes there were still defects in spermatogenesis, indicating that RARA 
has some function in spermatogonia [137, 138]. Furthermore, it was reported that conditional 
deletion of Rara and Rarg in spermatogonia resulted in a more severe phenotype than loss of 
Rarg alone, although the results were incompletely reported [135]. Taken together, this indicates 
that RARA is present at low levels in spermatogonia and that it can partially compensate for loss 
of RARG. Despite RARG being the most readily detectable RAR in spermatogonia, analysis of 
germ cell specific Rarg-null mice revealed that young mice had quantitatively normal 
spermatogenesis, but as mice aged there was an increase in the number of degenerated tubules 
[135]. Conditional deletion of Rara and Rarg in spermatogonia fails to even closely recapitulate 
the VAD phenotype, as spermatogenesis appears normal in the majority of seminiferous tubule 
segments. These results suggest two possibilities regarding RA-induced spermatogonial 
differentiation: 1) there is functional redundancy between other RARs (such as RARB) that are 
not usually expressed in wild type spermatogonia, or 2) RA signals spermatogonial 
differentiation through an RAR-independent mechanism. Further research is required to 
distinguish between these possibilities, and may be accomplished by deleting all three RAR 
subtypes concurrently in Sertoli cells and spermatogonia. 
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G. Transcriptional changes during spermatogonial differentiation 
A number of transcription factors are required for spermatogonial function, and many of 
these are uniquely expressed in spermatogonia. The majority of transcription factors identified so 
far in spermatogonia are required to maintain the undifferentiated state rather than to direct 
spermatogonial differentiation. Of the transcription factors required for SSC maintenance, many 
are induced downstream of GDNF signaling [BCL6B, BRACHYURY (T), ETV5, ID4, LHX1, 
and POU3F1 (reviewed by [139])], while others are regulated independent of GDNF (FOXO1, 
ZBTB16, POU5F1, and TAF4B). This suggests that there are GDNF-dependent and GDNF-
independent gene expression programs regulated at the transcriptional level. Some of these 
transcription factors function to maintain the SSC pool, while others presumably function in 
progenitor spermatogonia prior to differentiation. The transcription factors required for 
spermatogonial differentiation include SOHLH1 and SOHLH2 (reviewed by [139]). In addition, 
SOX3 is expressed in undifferentiated spermatogonia and is required during spermatogonial 
development and for the appearance of spermatocytes during the first wave of spermatogenesis. 
However, there does not appear to be an absolute requirement for this factor in spermatogonial 
differentiation as spermatogenesis recovers as Sox3-null mice age [140-142]. In contrast, 
SOHLH1 and SOHLH2 proteins are faintly detectable in undifferentiated spermatogonia and are 
upregulated by RA signaling [143]. They presumably function to regulate gene expression in 
differentiated spermatogonia as they proceed towards meiosis because deletion of either gene 
causes a block in spermatogonial differentiation [94, 144].  
RA is a requisite driver of spermatogonial differentiation. The best-studied function of 
RA is genomic, in which RA stimulates transcription by binding RARs present on discrete DNA 
sequences in target gene promoters termed RA response elements (RAREs) (reviewed by [131]). 
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In the testis, RA treatment increases steady-state mRNA levels for genes such as Dmc1, Stra8, 
Sycp3, and Rec8, which encode proteins essential for meiotic initiation [91, 97, 145-149]. RA 
treatment also increases steady-state mRNA levels of Cyp26a1 and Cyp26b1, which both encode 
enzymes that degrade RA [150]. Therefore, RA levels are tightly regulated and RA signaling is a 
self-limiting event, which allows important temporal control over differentiation and meiotic 
entry. These controls presumably regulate the exposure of discrete segments of the seminiferous 
tubules to RA, such that the highest levels occur at stages VII-VIII of the seminiferous epithelial 
cycle [151]. This allows RA signaling to direct spermatogonial differentiation and meiotic entry 
as well as spermiation of condensed spermatids, which occurs during these stages.  In addition to 
stimulating the transcription of target genes, there is evidence that RA can also inhibit 
transcription. In the absence of RA, RARs are bound to the promoter of Pou5f1 (also called 
Oct4), which encodes a transcription factor required for stem cell pluripotency that is also 
expressed in undifferentiated spermatogonia [152]. Binding of RA causes RAR to exit the 
promoter, leading to subsequent suppression of Pou5f1/Oct4 transcription.  
Multiple gene expression analyses have been performed to assess the transcriptome of 
whole testes as well as isolated spermatogonia to identify changes in steady-state mRNA levels 
over developmental time, in response to various stimuli, or following the loss of gene function 
through spontaneous mutation or gene ablation [153-155]. One recurring theme arising from 
these studies is there are relatively small numbers of genes with changes in mRNA abundance 
during spermatogonial development. In other words, there are relatively few identified changes 
in the spermatogonial transcriptome as SSCs transition to undifferentiated progenitors or as 
spermatogonia differentiate. This has provided scientists with a limited number of target genes 
and their associated cellular processes and pathways to study, which is a primary reason so little 
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is known about the process of spermatogonial development. It is clear that alternative approaches 
are needed to elucidate the complex mechanisms that control spermatogonial biology. 
 
H. Translational control during spermatogonial differentiation 
It has been known for many years that not all mRNAs are translated into protein with 
similar efficiency: mRNAs can be stored, inefficiently or efficiently translated, or targeted for 
degradation [156]. Progression to one of these biochemical fates allows for an important level of 
control over gene expression for rapid and large-scale responses to developmental stimuli. 
Prospermatogonia and undifferentiated spermatogonia contain mRNAs that are poorly translated 
(e.g. Sohlh1 and Sohlh2) or not translated at all (e.g. Kit), and we recently reported that these 
repressed mRNAs become efficiently translated as spermatogonia differentiate [157-159]. There 
are multiple reasons to suspect that translational control is a major regulator of gene expression 
during spermatogonial development. First, there is precedent from lower organisms; early germ 
cell fate commitments are based largely on proteins produced from derepressed mRNAs in 
Drosophila, C. elegans, and Xenopus [160, 161]. Second, as mentioned above, there are few 
changes in steady-state mRNA abundance accompanying spermatogonia differentiation (Figure 
1.3) [91, 153, 154, 158]. Third, a number of essential RNA binding proteins have been identified 
in spermatogonia (e.g. NANOS2, NANOS3, DAZL, TIAR, PIWIL2/MILI, PIWIL4/MIWI2, 
DDX4/VASA) with roles in mRNA degradation or translational repression/activation [162-168]. 
Fourth, numerous non-coding RNAs (miRNAs, piRNAs, and lncRNAs), which can regulate 
mRNA stability, degradation, and translation, are differentially expressed in undifferentiated and 
differentiated spermatogonia [89, 169-174]. And finally, prospermatogonia and spermatogonia 
contain electron-dense ‘nuage’, germ cell-specific structures adjacent to mitochondria that are 
found in at least 80 different species [175, 176]. These structures are involved in genomic 
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defense against transposable elements, and also function in RNA metabolism and storage, 
potentially serving as temporary repositories for repressed mRNAs [177-179].  
The activation/derepression of translationally controlled mRNAs is accomplished 
predominantly at the level of initiation by EIF4 translation factors. EIF4E and EIF4G regulate 
selective recruitment of translationally controlled mRNAs to ribosomes, particularly during germ 
cell differentiation in lower organisms [160, 161, 180-182]. Selective recruitment of mRNAs 
occurs via the binding of the mRNA cap-binding protein EIF4E to the scaffolding protein EIF4G 
that associates with ribosome subunits [183]. EIF4E may be sequestered from this recruitment by 
the inhibitory binding protein EIF4EBP1. Phosphorylation of EIF4EBP1 by mTOR releases 
EIF4E to associate with EIF4G and recruit mRNAs. Free EIF4E is essential for mRNAs with 
inordinate reliance on cap-recognition, typically growth-regulated mRNAs with complex 
secondary structure [184, 185]. EIF4EBP1 phosphorylation is a measure of enhanced cap-
dependent, growth-promoting protein synthesis [186]. Phosphorylation of EIF4EBP1, increases 
in germ cells from P1 to P4 [158], suggesting an increase in cap-dependent translation. 
Furthermore, recent studies from our laboratory and others have demonstrated that 
phosphorylation of the mechanistic target of rapamycin (mTORC1) is low/absent in SSCs and 
increases in proliferating and differentiating spermatogonia [157, 187]. Taken together, this 
implies that cap-dependent translation is an important factor controlling gene expression during 
spermatogonial differentiaiton.  
 
I. Rationale for current study 
RA directs the sequential programs of spermatogonial differentiation and meiotic 
initiation. These processes are temporally separated by approximately 1 week in the neonate, and 
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occur in different cell types (type A spermatogonia and preleptotene spermatocytes, 
respectively). This is in contrast to RA signaling in the fetal ovary, in which female germ cells 
enter meiosis approximately 24 h after initiation of RA signaling. The reason for this delay in the 
testis is unclear, although it is likely because of the requisite progression of stimulated cells 
through a number of intermediate differentiated spermatogonial types (A1-4, In, and type B 
spermatogonia). Administration of exogenous RA can induce the expression of markers of 
spermatogonial differentiation (STRA8, KIT, SOHLH1, and SOHLH2), which implies the initial 
steps of differentiation from undifferentiated progenitors or prospermatogonia and meiotic 
initiation by preleptotene spermatocytes. However, no study has yet demonstrated that 
spermatogonia can be stimulated to directly enter meiosis [96, 97, 188]. This indicates that there 
are a number of important changes during spermatogonial differentiation that must be completed 
prior to meiotic initiation.  
As mentioned above, a primary reason for the lack of knowledge about spermatogonial 
differentiation is that there are very few changes in steady-state mRNA levels between 
undifferentiated and differentiating spermatogonia. Messenger RNAs that encode crucial 
determinants of spermatogonia differentiation (i.e. KIT, SOHLH1, and SOHLH2) are abundant 
in undifferentiated spermatogonia but their respective protein products are either undetectable 
(KIT) or expressed at low levels (SOHLH1 and SOHLH2). There is compelling evidence from 
other systems that RA can utilize alternative, non-genomic pathways via activation of kinase 
signaling cascades [189, 190]. For example, the RARA subtype was shown in a neuronal cell 
line (SH-SY5Y) to be bound to the p85 regulatory subunit of PI3K [189]. Addition of RA led to 
recruitment of the p110 catalytic subunit, which induced rapid phosphorylation of MAPK1 and 
AKT (also known as PKB) [189]. Furthermore, RA activation of PI3K was shown to be required 
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for the differentiation of the F9 embryonal carcinoma cell line [190]. We recently showed that 
3,000 genes increase in heavy polysome occupancy [158]. Which was associated with an 
apparent increase in cap-dependent translation in whole testes from P1-4. The timing of this 
increase in translational efficiency corresponds directly to the period of initial RA signaling in 
the neonatal testis.  
MTORC1 is a multifunctional kinase complex that is activated downstream of PI3K-
AKT and can stimulate cap-dependent translation. This increase in translation occurs because 
mTORC1 phosphorylates EIF4EBP1 (releasing EIF4E) and RPS6KB1/2 (also called P70S6K, 
and this phosphorylation leads to ribosome activation) (reviewed by [191, 192]). These changes 
are linked to increased cellular growth, proliferation, and differentiation. A recent study revealed 
that mTORC1 suppression is important for SSC maintenance, [111, 193]. The authors proposed 
that ZBTB16 induces the expression of DDIT4 (also called REDD1), which functions to repress 
mTORC1 activation. However, this proposed mechanism is likely more complex than imagined, 
as maintenance of the SSC population is unaffected in the Ddit4-null mouse [194], and ZBTB16 
is expressed in both Aundiff and Adiff spermatogonia during neonatal testis development [95]. In 
contrast, activation of mTORC1 in differentiating spermatogonia correlates well with the 
increase in translational efficiency from P1-4 that we previously documented [158]. Previous 
work from our lab, as well as numerous reports from laboratories studying other organ systems, 
suggest that RA can act through both genomic (e.g. transcription) and non-genomic (e.g. kinase 
pathway activation) mechanisms (reviewed by [195]), but no study has yet demonstrated that this 
is occurs in mammalian male germ cells. We propose a mechanism whereby RA increases the 
translation of mRNAs required for spermatogonia differentiation (Kit, Sohlh1, and Sohlh2) by 
activating the PI3K-AKT-mTORC1 signaling network.  
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J. Specific Aims 
Aim 1. Characterize RA-induced changes during the prospermatogonia-to-spermatogonia 
transition in the neonatal testis. 
Hypothesis: RA promotes germ cell proliferation, Golgi and mitochondria maturation, 
expression of differentiation markers, and also advances entry into meiosis in the neonatal testis. 
It has been known for a long time that RA signaling is required for spermatogonial 
differentiation in the mouse testis. However, the cellular responses downstream of RA signaling 
remain uncharacterized. We will treat neonatal mice with exogenous RA prior to normal 
endogenous exposure, which occurs at P3-4, and characterize the subsequent cellular changes. 
Key cellular responses that we will focus on are how RA affects spermatogonial mitochondrial 
maturation and Golgi body size and activity (both assessed by morphology), proliferation, 
apoptosis, and the expression of differentiation markers such as STRA8, KIT, and SOHLH1. The 
results from this aim will clarify cellular changes occurring in spermatogonia in response to RA. 
 
Aim 2. Determine the mechanism/signaling pathway by which RA stimulates translation of 
repressed Kit mRNAs in the neonatal testis. 
Hypothesis: RA activates the PI3K-AKT-mTOR signaling pathway to stimulate translation of 
preexisting Kit mRNAs. 
Preliminary data indicate that RA stimulates the translation of Kit mRNAs that are present but 
not translated in undifferentiated spermatogonia. We will maintain neonatal testes in hanging 
drop cultures to define the mechanism by which Kit mRNAs are translated in response to RA. Ex 
vivo testis cultures will be pretreated with inhibitors to essential signaling network components 
(e.g. PI3K, PDPK1, AKT, mTOR, and MAPK1) followed by administration of RA to determine 
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which pathways are required for RA-induced expression of STRA8 and KIT. The results from 
this aim will increase our understanding of the complex mechanisms by which RA directs 
translation of repressed mRNAs during spermatogonial differentiation. 
 
Aim 3. Determine whether RA signaling through mTOR is required for the efficient 
translation of mRNAs required for spermatogonia differentiation in vivo.  
Hypothesis: RA signals through mTOR in vivo to stimulate the efficient translation of repressed 
mRNAs encoding essential determinants of spermatogonial differentiation. 
Preliminary evidence indicates that RA stimulates the efficient translation of Kit, Sohlh1, and 
Sohlh2 mRNAs. These encode proteins that are required for spermatogonial differentiation. The 
results from aim 2 reveal that treatment of neonatal mice with exogenous RA resulted in 
phosphorylation of mTOR (implying activation) in vivo. Therefore, we will treat neonatal mice 
with rapamycin, which specifically inhibits mTORC1, prior to the time of endogenous RA 
signaling at P3-4. This will allow for the determination of whether mTORC1 activation is 
required for spermatogonial differentiation as well as discover how inhibition affects RA-
induced translation of Kit, Sohlh1, and Sohlh2 mRNAs. 
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Figure 1.1 Prospermatogonia migrate to the periphery of the seminiferous cords 1-2 days after 
birth. At birth (P0), prospermatogonia are located at the center of the seminiferous cords. By P1-
2, most prospermatogonia have migrated to the periphery and are in contact with the basement 
membrane. 
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Figure 1.2 Model for spermatogonial development in the neonatal testis.  Prospermatogonia 
(white) transition to a heterogeneous population of differentiating (red), progenitor (yellow) and 
stem cell (grey) spermatogonia. Populations of differentiating spermatogonia enter meiosis, 
while the SSCs remain undifferentiated to provide a consistent source of differentiated 
spermatogonia after the first wave of spermatogenesis.  
This figure was modified and reprinted from Reproduction 149, 329-338 (2015), (see Appendix 
C) [95]. 
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Figure 1.3 Translational efficiency increases during neonatal testis development. A 
representation of the results from translation state array analysis and previous microarray results 
[154] depicting relative numbers of testicular mRNAs that increased ≥2-fold in abundance 
(black), became enriched ≥2-fold in heavy polysomes (green), or were unchanged (blue) from 
P1-4.  
This figure was modified and reprinted from Biology of Reproduction 89, 61-71 (2013), (see 
Appendix D) [158]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER II: RETINOIC ACID INDUCES MULTIPLE HALLMARKS OF 
THE PROSPERMATOGONIA-TO-SPERMATOGONIA TRANSITION IN 
THE NEONATAL MOUSE 
 
This chapter is modified and reprinted from Biology of Reproduction, 90, 64-73 (2014), see 
Appendix D. 
 
A. Summary 
In mammals, most neonatal male germ cells (prospermatogonia) are quiescent and 
located in the center of the testis cords. In response to an unknown signal, prospermatogonia 
transition into spermatogonia, reenter the cell cycle, divide, and move to the periphery of the 
testis cords. In mice, these events occur by P3-4 days, which temporally coincides with the onset 
of RA signaling in the neonatal testis. RA has a pivotal role in initiating germ cell entry into 
meiosis in both sexes, yet little is known about the mechanisms and cellular changes downstream 
of RA signaling. We examined the role of RA in mediating the prospermatogonia-to-
spermatogonia transition in vivo and found that 24 h of precocious RA exposure induced germ 
cell changes mimicking those that occur during the endogenous transition at P3-4. These changes 
included: 1) spermatogonia proliferation; 2) maturation of cellular organelles; and 3), expression 
of markers characteristic of differentiating spermatogonia. We found that germ cell exposure to 
RA did not lead to cellular loss from apoptosis, but rather resulted in a delay of approximately 2 
days in their entry into meiosis. Taken together, our results indicate that exogenous RA induces 
multiple hallmarks of the transition of prospermatogonia to spermatogonia prior to their entry 
into meiosis. 
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B. Introduction 
 Following sex determination, primordial germ cells in male mice become 
prospermatogonia at approximately E12.5, proliferate briefly, and become arrested in G0/G1 of 
the cell cycle from E14.5 until P1-2 [32, 65-67]. Then, in response to an undefined signal(s), 
they move from a central position to the periphery of the testis cords and resume mitosis as 
spermatogonia. Completion of both migration and mitosis is required for their continued survival 
[67]. This move positions them in a potential stem cell niche, flanked by Sertoli cells within the 
cord and peritubular myoid cells outside the cord. The transition of quiescent prospermatogonia 
into distinct proliferating populations of type A spermatogonia marks the beginning of 
spermatogenesis. One population of undifferentiated type A spermatogonia (As-Aal) retains stem 
cell potential to ensure long-term maintenance of the germline through balanced self-renewal and 
differentiation, whereas the other population of differentiating type A spermatogonia (A1-4) is 
thought to be committed to ultimately enter meiosis (reviewed in [82, 196, 197]). The first wave 
of spermatogenesis does not rely upon stem cell function but rather on differentiating 
spermatogonia that arise directly from the founding pool of prospermatogonia [73]. It has been 
suggested that germ cells that fail to make this transition provide the source for carcinoma in 
situ, the precursor lesion to the majority of testicular germ cell tumors in humans [198-200].  
 RA has a central role in regulating the sex-specific timing of meiotic initiation in mouse 
germ cells [54, 55, 201-203]. RA is produced by the mesonephroi of both sexes by E13.5 and 
enters the adjacent gonad. In the fetal ovary, RA signaling coincides with meiotic initiation at 
E13.5 [54, 55], although there its role remains to be clarified [204]. In contrast, RA in the fetal 
testis is degraded by CYP26 enzymes such as CYP26B1, which effectively blocks RA signaling 
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in prospermatogonia [54, 55, 57]. Differentiation leading to meiotic initiation is therefore 
delayed until P3-4 in the testis when RA is no longer actively degraded [54, 55, 91]. The current 
understanding of RA function in the neonatal testis in vivo is rather limited. The only currently 
known specific role of RA is activation of the germ cell-specific gene Stra8, which encodes a 
protein that is essential for germ cell development, although its precise role is unknown [145, 
148, 205]. It was previously shown that neonatal RA injection led to transient increases in Stra8 
and Sycp3 mRNA and protein levels after 24 h [97], followed by a modest increase in germ cell 
apoptosis [97, 206]. These neonatal RA injections resulted in significant stage synchronization in 
the adult [97, 206]. In other studies, spermatogonial differentiation was blocked in prepubertal 
mice in two genetic models with defective RA storage or production, respectively [207, 208]. 
Despite intense interest in the processes of germ cell differentiation and meiotic initiation, little 
is known about the cellular changes that occur downstream of RA during germ cell development. 
 In this study, we administered exogenous RA to mice at P1 (2 days before their 
endogenous exposure) and determined the downstream consequences for germ cell development. 
We found that precocious RA exposure induced germ cell changes mimicking those that occur 
during the endogenous transition. These include: 1) proliferation, 2) maturation of cellular 
organelles, and 3) expression of markers characteristic of differentiating spermatogonia. We then 
followed the fate of these spermatogonia for several days and found that they were not lost by 
apoptosis, but rather became transiently arrested before entering meiosis 2-3 days later than 
controls. This temporary arrest coincided with a transient increase in the expression of Cyp26a1 
and Cyp2b1, which encode RA degrading enzymes. This unexpected delay in meiotic entry 
following early RA exposure suggests that a consistent source of RA is required for neonatal 
germ cell progression to meiosis. 
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C. Materials and Methods 
C1. Neonatal Mouse Injection and Tissue Fixation  
 All procedures using animals were performed according to the guidelines outlined in the 
National Research Council Guide for the Care and Use of Laboratory Animals and approved by 
the Animal Care and Use Committee at East Carolina University (AUP no. A178). CD-1 mice 
were used for all studies, and the day of birth was designated as P0. Neonatal mice received one 
subcutaneous injection of 50 or 100 µg of all-trans-RA (catalog no. R2625; Sigma-Aldrich) 
dissolved in dimethyl sulfoxide (DMSO) (vehicle) or vehicle alone at P1. Bromodeoxyuridine 
(BrdU; catalog no. B9285; Sigma-Aldrich) was dissolved in DMSO (vehicle) and 50 µg/g body 
weight was injected with or without RA. Mice were euthanized by decapitation at various time 
points after injections. Testes were then collected and either snap-frozen in liquid nitrogen and 
stored at −80°C or fixed in 4% paraformaldehyde (PFA) for cryosectioning or in Bouin solution 
(for histological analysis). 
 
C2. Quantitative RT-PCR 
 Quantitative RT-PCR (qRT-PCR) was performed with RNA isolated from whole testis 
lysates, using Trizol reagent (Life Technologies) according to the manufacturer's instructions and 
then quantitated by ultraviolet spectroscopy. Fifty nanograms of RNA were reverse-transcribed 
and subjected to qPCR in the same reaction tube using iScript One-Step RT-PCR kit with SYBR 
green (Bio-Rad). Amplification and detection of specific gene products were performed using an 
iCycler IQ (Bio-Rad) real-time PCR detection system. Threshold temperatures were selected 
automatically, and all amplifications were followed by melt-curve analysis. Relative mRNA 
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levels were calculated using the delta-delta cycle threshold (ddCt) method: mRNA fold-change 
level = (2−ddCt), where ddCt = [dCt gene of interest in treated group − [dCt of gene of interest in 
control group], where dCt = the [Ct gene of interest] – [Ct of reference gene]. Ct values were 
normalized to those of Rpl19, and qRT-PCR was performed in triplicate with testes from at least 
4 animals. 
 
C3. Histology and Indirect Immunofluorescence 
 Whole testes fixed in Bouin’s solution for 2 h at 4°C were washed overnight in 1X PBS, 
dehydrated through an ethanol series, processed using standard methods, and then embedded in 
paraffin and cut into 5-µm sections.  Sections were stained with hematoxylin and eosin (H&E) 
using standard methods. Immunohistochemistry (IHC) on Bouin’s-fixed sections using anti-
RHOX13 was done as described previously [93, 209].  
 Indirect immunofluorescence was performed using standard methods. Briefly, 5-µm 
frozen sections were cut from tissues that were fixed in 4% PFA and embedded in OCT. 
Blocking and antibody incubations were carried out in 1× PBS containing 3% BSA plus 0.1% 
Triton X-100, and stringency washes were done with 1× PBS plus 0.1% Triton X-100. For 
staining with anti-BrdU, sections were first incubated in 2M HCl for 1 h at 37°C to expose 
epitopes. All sections were blocked for 30 min at room temperature and then incubated in 
primary antibody for 1 h at room temperature or overnight at 4°C. Primary antibody was omitted 
as a negative control. Primary antibodies used were anti-ZBTB16 (1:500 dilution, no. 22839, 
Santa Cruz Biotechnology), anti-STRA8 (1:3000 no. 49–602, Abcam), anti-KIT (1:1000 
dilution, no. 3074, Cell Signaling Technology), anti-SOHLH1 (1:1000 dilution, a gift from A. 
Rajkovic, U. of Pittsburgh [210]), activated anti-cleaved CASP3 (1:500 dilution, no. 9664, Cell 
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Signaling Technology), anti-MKI67 (1:500 dilution, no. 15580, Abcam), anti-BrdU (1:50 
dilution, no. 00–0103, Life Technologies), and anti-cleaved PARP1 (1:400 dilution, no. 9544, 
Cell Signaling Technology). Secondary antibody (1:500 dilution, Alexa Fluor-488 or −594 
donkey anti-rabbit immunoglobulin G [IgG], Invitrogen) plus phalloidin-594 (1:500 dilution, 
Invitrogen) were applied for 1 h at room temperature. Coverslips were mounted with Vectastain 
containing 4′,6-diamidino-2-phenylindole (DAPI; Vector Laboratories), and images were 
obtained using a Fluoview FV1000 confocal laser-scanning microscope (Olympus America). All 
immunostaining was performed in triplicate with testes from at least 4 animals. 
 
C4. Cell Counting 
 Male germ cells were manually counted from photomicrographs of immunostained 
sections captured with an Axio Observer A1 microscope (Carl Zeiss Microscopy) equipped with 
an XL16C digital camera and Exponent version 1.3 software (Dage-MTI). Germ cells were 
immunostained with antibodies against ZBTB16 (see above), and testis cords were visualized by 
staining with phalloidin-594 (see above). Photomicrographs were analyzed using Axiovision 
software (Carl Zeiss Microscopy). Testis cords were outlined manually using phalloidin staining 
as a guide, and the total germ cell numbers were divided by total cord surface area and multiplied 
by 1000 to obtain cells/mm2. Cell counting was performed in duplicate on testes from at least 4 
animals. 
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C5. Electron Microscopy  
 Testes were cut into 1- to 3-mm pieces and fixed for 2 h in 2% glutaraldehyde and then 
post-fixed in 1% osmium tetroxide (Stevens Metallurgical). Tissues were then dehydrated by 
passage through an ethanol series and embedded in Spurr’s medium (Electron Microscopy 
Sciences). Tissues were cut into ultrathin sections (70 nm) and placed on fresh plasma-etched 
200-hexagon mesh copper grids (Electron Microscopy Science). Sections were stained in 
saturated uranyl-acetate in 50% ethanol for 30 min at room temperature in a humid chamber, 
washed in distilled water, and then stained with Reynold’s lead citrate for 5 min at room 
temperature. Sections were viewed with a 1200 EX electron microscope (JEOL) at 80-kV 
accelerating voltage. Images were recorded using an SIS MegaView III charge-coupled device 
camera (Olympus). Electron microscopy was performed using testes from 6 different animals. 
 
C6. Statistical analysis 
  Statistical analyses were performed using the Student t-test. Statistical significance was 
set at a P value of ≤0.05. 
 
D. Results 
D1. Neonatal RA treatments induce Stra8 expression 
 RA provides a requisite signal for the development of spermatogonia in juvenile and 
adult mice [117, 202, 211, 212]. To study the effects of RA on neonatal testis development, we 
adapted an in vivo model in which neonatal mice were injected with all-trans-RA at P1, 2 days 
prior to their normal endogenous exposure at P3–P4 (Fig. 2.1A, [91]). Expression of Stra8 
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mRNA and protein provided evidence of RA signaling in germ cells, and both were detectable 
by P3–P4 in a subset of spermatogonia (Fig. 2.1B and C, [91, 97]). This timing coincides with 
the natural prospermatogonia-to-spermatogonia transition in the neonatal mouse testis. Injection 
of 50 or 100 µg of exogenous RA at P1 significantly increased the number of STRA8+ germ 
cells (∼18-fold), observed by immunostaining, relative to vehicle-treated controls (Fig. 2.1D and 
E, quantitated in Fig. 2.1F), and induced Stra8 mRNA similar to the levels measured in P4 testes 
(Fig. 2.1G). Similar Stra8 induction has been shown previously following RA injection into mice 
at P2 [211]. Both of the doses of RA consistently induced STRA8 protein. However, injection of 
100 µg of RA reduced animal survival rates after 48 h, so we used 50 µg for experiments that 
involved longer periods prior to euthanasia. 
 
D2. RA stimulates proliferation of neonatal germ cells 
 The male germ cell population approximately doubles from P1-4 in the mouse [158] and 
this reflects a reentry into the cell cycle as prospermatogonia transition to spermatogonia 
(reviewed in [213]). The timing of germ cell proliferation corresponds with onset of RA 
signaling in the neonatal testis [91, 211]. We therefore hypothesized that, prior to its proposed 
role in meiotic initiation (at P8-10 in the mouse), RA directs postnatal expansion of the germ cell 
population. To test this hypothesis, we injected mice with vehicle or RA at P1, euthanized them 
24 h later, and then stained germ cells with MKI67, an established marker of nuclear 
proliferation [214]. We detected a dramatic increase in the number of MKI67+ germ cells 
(identified by appearance and diameter of DAPI-stained nuclei) in response to RA (Fig. 2.2A and 
B). To verify that the MKI67+ cells that had reentered the cell cycle were indeed germ cells, we 
first injected mice at P1 with BrdU and either vehicle or RA. We then harvested testes and co-
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immunostained sections with anti-BrdU and anti-ZBTB16 and found that 25% ± 2.1% of 
ZBTB16+ cells in vehicle-treated testes were positive for BrdU. In contrast, 40% ± 9.7% of 
ZBTB16+ cells were also BrdU+, which was a significant increase (P = 0.015), and indicated 
that RA stimulated more germ cells to replicate their DNA in preparation for cell division (Fig. 
2.2C and D). 
 We quantified the increased number of male germ cells in vehicle- and RA-treated mice. 
Discrimination between Sertoli and germ cell nuclei is rather straightforward in DAPI-stained 
sections of the neonatal testis; the small ovoid Sertoli cell nuclei contain intense heterochromatic 
foci, whereas both prospermatogonia and spermatogonia nuclei are large and round and contain 
very little heterochromatin [215]. We identified germ cells by using these criteria along with 
staining for DDX4, a pan-germ cell marker (Fig. 2.2E and F, [216, 217]). Therefore, we counted 
DDX4+ in both treatment groups (Fig. 2.2 G and H) and expressed the totals as a fold-change in 
DDX4+ germ cells per square millimeter of testis cord.  In testes from RA-treated mice, there 
were approximately 1.43-fold more DDX4+ germ cells than in vehicle controls (Fig. 2.2I). In 
addition, we labeled germ cells with anti-ZBTB16, which is expressed in prospermatogonia and 
spermatogonia [85, 218], and found that all germ cells in the neonatal testis were ZBTB16+ (Fig. 
2J-M). This approach accounted for the various sizes and shapes of cord sections and the 
seemingly stochastic number of total germ cells per cord. In testes from RA-treated mice, there 
were approximately 1.4-fold more ZBTB16+ germ cells than in vehicle controls (Fig. 2.2O).  
 
D3. RA induces expression of differentiation markers in spermatogonia 
 The injection of exogenous RA induced precocious expression of Stra8 and Sycp3 
mRNAs and STRA8 protein in neonatal male germ cells after 24 h (Fig. 2.1 and [97]). To 
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address whether RA induced expression of markers characteristic of differentiating 
spermatogonia, we stained vehicle- and RA-treated testes for SOHLH1 and KIT protein (Fig. 
2.3A-D). KIT protein was detectable in some Leydig cells as previously reported, and there was 
no increase in KIT+ interstitial cells in response to RA. There were a very small number of germ 
cells in which KIT was faintly detectable in vehicle-treated testes  (Fig. 2.3A). However, 
treatment with exogenous RA at P1 caused a dramatic increase in KIT+ germ cells (Fig. 2.3B). 
Similarly, germ cells in vehicle-treated testes expressed low levels of SOHLH1 (Fig 2.3C), 
which increased dramatically following treatment with RA (Fig 2.3D). 
 
D4. RA treatment stimulates germ cell mitochondria biogenesis and Golgi maturation  
 A number of laboratories painstakingly characterized changes in the ultrastructure of 
prospermatogonia and spermatogonia, including mitochondrial and Golgi morphologies [67, 
219-221]. In agreement with these reports, we found that mitochondria in prospermatogonia at 
P1 were relatively undeveloped and appeared round with few, indistinct cristae (Fig. 2.4A-C). 
Few prospermatogonia had visible Golgi bodies, and those present consisted of 2–3 laminar 
stacks and few accompanying vesicles (Fig. 2.4A-C). However, by P4, most germ cell 
mitochondria had increased numbers of cristae (Fig. 2.4D-F) and Golgi complexes were more 
numerous, with extensive laminar stacks and large numbers of budding vesicles (Fig. 2.4D-F). 
Treatment of mice with vehicle did not result in an appreciable change in mitochondria or Golgi 
complexes as compared to those at P1 (Fig. 2.4G-I). In stark contrast, RA treatment resulted in 
mitochondria with an increased number of electron-dense cristae, and Golgi bodies resembled 
those in P4 germ cells (Fig. 2.4J-L).  
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The transmission electron microscopy was performed in collaboration with Dr. Randall 
Renegar. 
 
D5. Precocious exposure to RA does not cause neonatal germ cell apoptosis 
We tested whether 24-h exposure to RA following injection at P1 induced germ cell 
apoptosis as was shown previously, following exposure of fetal and neonatal prospermatogonia 
to RA [58, 97, 206, 222]. We assessed germ cell apoptosis at 48 h (age = P3) and 72 h (age = P4) 
following RA administration by using 3 different methods: 1) immunostaining using antibodies 
to detect an active caspase (cleaved CASP3) and a caspase cleavage target (PARP1); 2) 
quantitation of the germ cell population; and 3) histological analysis of H&E-stained sections to 
quantitate cells with apoptotic features. We found no significant increase in cleaved PARP1 in 
response to RA compared to that in vehicle controls at 48 or 72 h after injection (Fig. 2.5A-E). 
Similar results were obtained by staining for cleaved CASP3 (Fig. 2.5F-I). Furthermore, there 
was no decrease in the germ cell population by 48 or 72 h post-RA treatment (Fig. 2.5J), as 
would be expected if there was an increase in cell death. Finally, light microscopy analysis 
revealed similar numbers of germ cells with apoptotic morphology in the RA- and vehicle-
treated testes at 48 and 72 h after RA treatment (Fig. 2.6A-D). Results from a previous study 
indicated that RA injection at P2 resulted in a modest increase in germ cell apoptosis after 48 h 
[97]. We repeated those experiments by injecting mice at P2 and euthanizing them 48 h later, but 
we did not detect an increase in apoptosis as assessed by staining for cleaved CASP3 (Fig. 2.6E 
and F). Taken together, our results reveal that RA does not promote germ cell apoptosis when 
given during the prospermatogonia-to-spermatogonia transition. 
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D6. The effects of RA on the fate of spermatogonia and the onset of meiosis 
Our results indicate that precocious RA exposure (at P1) caused prospermatogonia to 
exhibit characteristics of early differentiating spermatogonia (proliferation and marker gene 
expression) and then that these spermatogonia were not removed by apoptosis. An open question 
is whether the germ cell population in RA-injected mice follows a normal timeline to enter 
meiosis at P10 or whether the timing of their entry into meiosis would be affected. To address 
this, we injected mice with either vehicle or 50 µg of RA at P1 and then harvested testes at P6, 
P8, P10, P12, and P14 to determine when the germ cell population entered meiosis. The reliable 
identification of specific premeiotic and meiotic germ cell types was made possible based on 
their location within the testis cord and characteristic nuclear diameter [215] and chromatin 
appearance [68]. To aid identification, we also labeled cells with an antibody against RHOX13, 
which is readily detectable in differentiating spermatogonia and preleptotene spermatocytes, 
faintly detectable in leptotene spermatocytes, and undetectable in zygotene and pachytene 
spermatocytes [93, 209]. Although we previously found that RA enhanced translation of Rhox13 
mRNAs in neonatal testes [93], we did not detect any difference in the cell types expressing 
RHOX13 in vehicle- or RA-treated testes after P8. In testes from CD-1 mice injected with 
vehicle, the first meiotic leptotene spermatocytes appeared as early as P8 in a small subset (5%) 
of testis cords (data not shown). By P10, meiotic leptotene spermatocytes were readily detectable 
[215], and present in a high number (approximately 40%) of the testis cords (Fig. 2.7A). 
Zygotene spermatocytes appeared in CD-1 mice in significant numbers at P12 [215]. We found 
them in 37% of cords at P12 (Fig. 2.7B), with this percentage increasing to 63% by P14 (Fig. 
2.7C). In RA-treated testes at P8, 1% of cords contained meiotic leptotene spermatocytes (data 
not shown), similar to vehicle-treated controls. By P10, only 15% of cords from RA-treated 
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testes contained leptotene spermatocytes (Fig. 2.7D), which was a significant reduction 
compared to vehicle treated controls. This percentage increased to 27% by P12 (Fig. 2.7E) and to 
86% at P14 (Fig. 2.7F). A small number of zygotene spermatocytes appeared in RA-treated 
testes by P10, and they were present in 10% and 12% of cords by P12 and P14, respectively (Fig. 
2.7, D–F). No histological evidence of increased germ cell apoptosis in the RA-treated testes was 
observed at any of these ages examined (data not shown). A comparison of the temporal 
appearance and abundance of specific germ cell types in these samples revealed that the P10 and 
P12 RA-treated testes resembled those from vehicle-treated testis of P8 and P10 mice, 
respectively. These results indicate that, contrary to our expectation that precocious RA would 
promote early meiotic initiation, it instead resulted in a 2–3 day delay, and testes appeared 
synchronized by P14. 
 
D7. Synchronization follows loss of RA signaling after exogenous RA treatment 
It was previously shown that testicular Stra8 and Sycp3 mRNA levels increased 24 h after 
RA injection, but then surprisingly decreased by 48 and 72 h later [97]. This coincided with a 
transient increase in mRNA levels for Cyp26a1 and Cyp26b1, which encode RA-degrading 
enzymes [97]. We verified those results using qRT-PCR to measure Cyp26a1 and Cyp26b1 
mRNA levels from whole testis lysates of mice euthanized 24, 48, and 72 h following injection 
with vehicle or RA at P1. By 24 h after treatment with RA, Cyp26a1 and Cyp26b1 mRNA levels 
were significantly increased; but, by 48 and 72 h after injection, Cyp26a1 levels had significantly 
decreased below that of control levels, whereas Cyp26b1 levels only were significantly reduced 
at 48 h post-RA treatment and returned to similar levels to those observed in vehicle-treated 
testes 72 h post-RA treatment (Fig. 2.8A and B). Furthermore, while Stra8 mRNA and protein 
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were dramatically increased 24 h after RA treatment (Fig. 2.1E and G), by 48 and 72 h after RA 
treatment, Stra8 mRNA levels were 10-fold and 7-fold decreased, respectively (Fig. 2.8C). 
Although STRA8 protein was readily detectable at 72 h post-vehicle treatment, it became 
undetectable by 72 h after RA injection (Fig. 2.8D). Stra8 mRNA levels increased from 48 to 72 
h post-RA treatment, which follows the dramatic decrease in Cyp26a1. This suggests that 
endogenous testicular RA levels may be restored as CYP26 enzyme levels decrease. 
 
E. Discussion 
 The current study was designed to assess downstream events in neonatal germ cell 
development initiated by RA, which provides an essential trigger for meiotic entry in both sexes 
[54, 55, 201]. Currently, little is known about the molecular events initiated by RA signaling 
during the interval as prospermatogonia transition to spermatogonia. We exposed 
prospermatogonia to exogenous RA at P1 at least 2 days earlier than their native exposure at P3–
P4. We discovered that early administration of RA induced precocious cellular proliferation and 
maturation of cellular organelles as well as expression of markers of differentiating 
spermatogonia. We then followed the fate of RA-exposed prospermatogonia and found that they 
were not subject to apoptosis but rather progressed to meiosis, although meiotic entry was 
delayed by approximately  2 days. This delay coincided with loss of RA signaling as assessed by 
loss of Stra8 mRNA and protein. This indicates that, in contrast to fetal prospermatogonia, 
prospermatogonia in the neonatal testis have gained competence to differentiate in response to 
RA and do not undergo apoptosis. 
When we injected exogenous RA into neonatal pups, there was increased proliferation, 
and a large percentage of spermatogonia became STRA8+ (Fig. 2.1F). In addition, RA-induced 
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germ cell expression of both KIT and SOHLH1, which, along with STRA8, are established 
markers of differentiating spermatogonia. It was shown many years ago that dramatic 
ultrastructure changes occur as prospermatogonia make the transition to spermatogonia. In 
comparison with quiescent prospermatogonia, mitotically active spermatogonia have increased 
cytoplasm/nucleus ratios, mitochondria with increased numbers of cristae, and prominent Golgi 
complexes and rough endoplasmic reticulum [67, 219-221]. These features are commonly found 
in proliferating cells and are suggestive of increased energy metabolism to support biosynthetic 
activity. In particular, mitochondrial biogenesis increases the capacity for oxidative 
phosphorylation through expansion of the surface area of the inner mitochondrial membrane. A 
number of studies have documented the importance of mitochondrial biogenesis during 
differentiation of embryonic, hematopoietic, mesenchymal, and induced pluripotent stem cells. 
In general, undifferentiated stem cells tend to have reduced mitochondrial function and rely on 
glycolysis, whereas differentiating cells contain active mitochondria with high membrane 
potential and increased oxidative phosphorylation (OXPHOS) (reviewed in [223, 224]). The 
increased reactive oxygen species in differentiating cells as a result of oxidative metabolism are 
also linked to cellular differentiation [225, 226].  
Fetal prospermatogonia exit the cell cycle at approximately E15.5 and become quiescent 
until approximately P2-P3 in the mouse. This quiescent period is likely established because germ 
cells avoid exposure to RA by the expression of CYP26 enzymes such as CYP26B1 [54, 55, 57, 
201], and is arguably the least well-understood period of male germ cell development. It is clear 
that germ cells undergo paternal-specific DNA methylation patterning during this interval [64], 
and are sensitive to environmental insults that presumably generate heritable epigenetic lesions 
[227, 228]. When fetal prospermatogonia were exposed to RA, they expressed meiotic markers 
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before dying by apoptosis [56, 58], indicating that they cannot commit to the meiotic program. In 
this study, we assessed whether postnatal prospermatogonia were similarly unable to both enter 
and proceed through meiosis. Administration of exogenous RA at P1 (2–3 days prior to 
endogenous exposure) caused prospermatogonia to both enter and proceed through meiosis, 
albeit delayed, without dying by apoptosis. These results indicate that, unlike fetal 
prospermatogonia, neonatal spermatogonia prior to P4 are competent to differentiate toward 
entering meiosis but are awaiting the RA signal to do so. 
We found rather low numbers of apoptotic cells within testis cords of the neonatal testis. 
Regardless of vehicle or RA treatment, only approximately 5%–10% of cords contained cells 
expressing markers of apoptosis (cleaved CASP3 or PARP1) or had morphology consistent with 
apoptosis. These results are consistent with those from a previous study, where approximately 
5% of testis cords in outbred ICR mice contained apoptotic cells from P3–P7 [229]. It was 
recently reported that apoptosis affected approximately  0.5 and 1 germ cell per testis cord in 
mice exposed at P2 for 24 h with vehicle or RA, respectively [97]. These germ cells stained 
positive for the activated effector CASP3 but curiously did not display fragmented or condensed 
nuclei, shrunken cytoplasm, or detachment from the basement membrane, which are typical 
markers of apoptosis (reviewed by [230]). If the cleaved CASP3+ germ cells observed in that 
study were evenly distributed throughout the testis, it would mean that approximately 50% and 
100% of cords from vehicle- and RA-treated mice contained an apoptotic cell(s) respectively. 
However, based on our estimates that there are approximately  5 germ cells per testis cord at P3, 
an increase of 0.5 to 1 germ cell/cord in apoptosis in response to RA equals a 10% increase in 
apoptosis affecting the germ cell population. The neonatal male germ cells in the C57Bl/6 × 129 
pups used in their studies were perhaps more susceptible to apoptosis than those in the CD-1 
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pups that we used. Even so, it is unlikely that such a modest increase in apoptosis 
(approximately  10%) would result in the extensive stage synchronization seen both in that study 
and in the current one (in which apoptosis was not increased in response to RA). 
The onset of RA signaling clearly has different consequences for the fate of male and 
female germ cells during development. Although RA signaling temporally coincides with 
meiotic entry of oocytes at approximately E13.5 [55, 63, 145, 231], the onset of RA signaling in 
the testis occurs at P3–P4 [91, 211]. This creates a 5- to 7-day window between exposure of 
prospermatogonia to RA and appearance of the first meiotic leptotene spermatocytes by P8–10 
[215]. It is unclear why there is such a marked sex-specific difference in the initial response of 
germ cells to RA. However, female mammalian germ cells lack two important features found in 
the male: an analogous stem cell population and initial developmental asynchrony. The delay of 
approximately 1 week between RA signaling and meiotic initiation corresponds to the time when 
the establishment of the spermatogonial stem cell population occurs in the neonatal testis [196]. 
By P4, only subsets of spermatogonia were STRA8+, which indicates that RA signaling does not 
occur in a significant proportion of spermatogonia at any particular time (in this study as well as 
in [91, 148, 211]). The expression of STRA8 in a limited number of germ cells indicates that 
there is a heterogeneous population of undifferentiated and differentiating spermatogonia by P3–
P4. The undifferentiated pool of spermatogonia appears to be protected from RA exposure (and 
remain STRA8-), whereas RA signaling occurs in differentiating spermatogonia over the next 5–
7 days. 
Precocious neonatal exposure to RA accelerated germ cell development by approximately 
48 h but then paradoxically delayed meiotic initiation by approximately 48 h 1 week later. This 
was a rather surprising result, as we reasoned that if the timing between normal RA exposure 
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(P3–P4) and meiotic initiation (P8–10) were maintained, then meiosis would initiate 2 days 
early. Our results instead support a model whereby neonatal spermatogonia require multiple or 
consistent exposure(s) to RA for committed differentiation to ultimately enter meiosis.   
In agreement with previous studies done both in vitro and in vivo [97, 155], we detected 
increased testicular mRNA levels for the RA-degrading enzymes Cyp26a1 and Cyp26b1 after 24 
h of exposure of P2 mice to exogenous RA. In both this and previous studies, dramatic decreases 
in both Cyp26a1 and Cyp26b1 mRNA abundance were then seen after the initial increase 
following RA exposure [97, 155]. The CYP26 enzymes function to degrade RA, and their action 
has been implicated in protection of undifferentiated spermatogonia from inappropriate exposure 
to RA [54, 55, 57, 201, 211]. In this experimental paradigm, it is likely that an initial increase in 
CYP26A1 or CYP26B1 degrades not only the injected exogenous RA but also the endogenous 
RA. This is supported by our result indicating STRA8 is lost 48 h after RA injection (Fig. 2.8D). 
A loss of RA provides a plausible explanation for the stalled germ cell development resulting in 
the 2- to 3-day delay in meiotic initiation observed in our study. This model presumes that RA 
levels recover a few days after the decreased CYP26 enzyme levels, which then allows germ 
cells to proceed toward meiosis at the same pace. This is supported by our observation that Stra8 
mRNA levels significantly increase from 48 to 72 h following RA treatment (Fig. 2.8C). Such a 
model would explain the synchronization seen at 12 and P14 in the current study and in adult 
mice in previous studies following modification of RA signaling [97, 116, 206]. It also reveals 
the fact that the initial differentiation of spermatogonia in response to RA (as indicated by their 
expression of STRA8, KIT, and SOHLH1) is reversible, as germ cells lose STRA8 expression 
after the increase in Cyp26 levels but then can apparently differentiate 2 days later to enter 
meiosis. 
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The results of the current study indicate that RA provides an instructive signal for 
neonatal prospermatogonia to transition into spermatogonia. Hallmarks of differentiation such as 
germ cell proliferation, cord organization, and expression of differentiated spermatogonia 
markers, characteristic of spermatogonia were all observed approximately 2 days before their 
natural progression. In contrast to previous results, we found that neonatal exposure to RA does 
not increase germ cell apoptosis but causes precocious spermatogonia development that is then 
halted for approximately 2 days, presumably by increased CYP26-dependent degradation of RA. 
Once Cyp26 levels decrease 48 h after RA exposure, endogenous RA levels are presumably 
restored, and differentiation continues such that synchrony of spermatogenesis is increased 
through adulthood.   
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Figure 2.1 RA treatment induces expression of Stra8 mRNA and protein. (A) Neonatal mice 
were injected at P1 and euthanized 24 h after injection. The normal endogenous RA signaling is 
initiated at P3-4. (B-E) Immunostaining was performed to detect STRA8 (green), and F-actin 
was stained with phalloidin (red) to visualize testis cords. Testes were from untreated mice aged 
P1 (B), P4 (C), or were from mice euthanized 24 h after injection at P1 with vehicle (D) or RA 
(E). (F) Testis sections from mice treated at P1 with vehicle or RA and then euthanized 24 h 
later were immunostained and the number of STRA8+ cells per square millimeter of testis cord 
were quantitated and expressed as a fold chance.  (G) Stra8 mRNA levels were quantitated from 
P1 and P4 testes as well as from testes from mice injected at P1 with either vehicle or RA and 
euthanized 24 h later. Message levels were normalized to the vehicle-treated group, which was 
set at 1. Scale bar=60 µm. Asterisk indicates statistical significance at (P<0.01). 
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Figure 2.2 RA treatment stimulates germ cell proliferation. Immunostaining was performed on 
testis sections from mice injected with vehicle (A, C, G, and L) or RA (B, D, H, and M) at P1 
and euthanized 24 h later, and from mice aged P1 (E and J) and P4 (F and K). Five-micrometer 
sections were used for detection of MKI67 (A and B both green), BrdU (B and C, both green), 
DDX4 (E-H, all green), and ZBTB16 (J-M, all green). Phalloidin (red) was added to highlight 
the outline of the testis cords. (I and O) The total number of DDX4+ (I) or ZBTB16+ cells (O) 
were determined, divided by the total cord area, and then multiplied by 1000 to calculate 
cells/mm2 and reported as a fold change from the vehicle-treated group. Scale bars=60 µm. 
Asterisk indicates statistical significance at (P<0.01). 
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Figure 2.3 RA treatment induced expression of the differentiation markers SOHLH1 and KIT. 
Immunostaining was performed with testis sections from ice euthanized 24 h after injection with 
vehicle (A and C) or RA (B and D) using antibodies for KIT (A and B, both green) or SOHLH1 
(C and D, both green) and phalloidin (red) was added to visualize testis cords.  Scale bar=60 µm. 
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Figure 2.4 RA treatment increased mitochondrial biogenesis and Golgi body development. 
Transmission electron micrographs show testes from mice aged P1 (A-C), P4 (D-F), or those 
euthanized 24 hours after treatment at P1 with vehicle (G-I) or RA (J-L). Black arrows indicate 
mitochondria and white arrows indicate Golgi stacks. (A and B) At P1, prospermatogonia 
mitochondria have few election-dense cristae (black arrows). (D and E) Spermatogonia 
mitochondria from P4 mice have numerous electron-dense cristae. (G and H) Similarly, 
mitochondria in germ cells from vehicle treated testes have few electron-dense cristae, whereas 
those of RA treated testes (J and K) contain numerous electron-dense cristae. Golgi bodies in 
prospermatogonia from P1 (C) and vehicle treated (I) testes appear small and indistinct, whereas 
Golgi bodies in germ cells of P4 (F) and RA-treated (L) testes are larger and appear active. Scale 
bar (in A)=5 µm; scale bar (in B)=1 µm.   
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Figure 2.5 Precocious RA exposure did not result in apoptosis. Immunostaining of 5-µm 
sections from mice treated with vehicle (A, C, F, and H) or RA (B, D, G, and I) at P1 and 
euthanized 48 h (A, B, F, and G) or 72 h (C, D, H, and I) post-treatment. Sections were probed 
with antibodies for anti- cleaved PARP1 (A-D, green) or anti- cleaved CASP3 (F-I, green). 
Phalloidin (red) was added to visualize testis cords and DAPI labeled nuclei (blue). White arrows 
indicate apoptotic cells. (E) Testis cord cross-sections that containing cells staining positive for 
cleaved PARP1 were counted and their numbers were divided by total testis cord cross-sections 
and multiplied by 100 to obtain the percentage of cleaved PARP1+ cords. (F) The total number 
of ZBTB16+ cells were determined, divided by the total cord area, and then multiplied by 1000 
to calculate ZBTB16+ cells/mm2. Scale bar=60 µm 
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Figure 2.6 RA treatment did not increase the number of germ cells with apoptotoic 
morphology. H&E of 5-µm sections from mice euthanized at P3 (A) or P4 (B) and from mice 
treated at P1 with RA and euthanized 48 h (C) or 72 h (D) later. Red arrows indicate 
representative apoptotic germ cells. (E and F) Immunostaining was performed on testis sections 
from mice injected at P2 with either vehicle (E) or 50 µg RA (B) and then euthanized 48 h later. 
Sections were probed with antibodies against cleaved CASP3. White arrows indicate cleaved 
CASP3+ cells (green), and F-actin is stained by phalloidin (red) to visualize testis cords and 
DAPI stained nuclei (blue). Scale bar (in A)=50 µm. Scale bar (in E)=60 µm. 
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Figure 2.7 Precocious RA exposure delayed meiotic entry. (A–F) Immunostaining was 
performed using testis sections from mice injected at P1 with either vehicle (A–C) or RA (D–F). 
Ages of mice are shown at the top: P10 (A and D), P12 (B and E), and P14 (C and F). An 
antibody was used to detect RHOX13 (brown), and sections were then counterstained with 
hematoxylin (blue). Orange arrows indicate preleptotene spermatocytes (A and D), yellow 
arrows indicate leptotene spermatocytes (A–F), and green arrows indicate zygotene 
spermatocytes (B, C, and E). G) Leptotene and zygotene spermatocytes were quantitated in cord 
cross-sections from each age. The numbers of cords containing leptotene and zygotene 
spermatocytes were divided by the total number of cords analyzed, and the result was multiplied 
by 100 to obtain the percentage of cords containing meiotic leptotene/zygotene spermatocytes. 
Black bars represent leptotene+ cords, and gray bars represent zygotene+ cords. Scale bar=50 
µm. Asterisks indicate statistical significance (P<0.01). 
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Figure 2.8 RA treatment induces expression of RA degrading enzymes. Cyp26a1 (A), Cyp26b1 
(B), and Stra8 (C) mRNAs were quantitated by qRT-PCR from mice euthanized 24, 48, and 72 h 
following treatment with vehicle or RA. D) Immunostaining was performed to detect STRA8 
(green), and F-actin was labeled with phalloidin (red) in testes harvested from mice 72 and 120 h 
after injection with either vehicle or RA. Scale bar=40 µm. Asterisks indicate statistical 
significance (P<0.01) and stars indicate (P< 0.05).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER III: RETINOIC ACID REGULATES KIT TRANSLATION 
DURING SPERMATOGONIAL DIFFERENTIATION IN THE MOUSE 
 
This chapter is modified and reprinted from Developmental Biology, 397, 329-338 (2015), see 
Appendix E. 
 
A. Summary 
In the testis, a subset of spermatogonia retains stem cell potential, while others 
differentiate to eventually become spermatozoa. This delicate balance must be maintained, as 
defects can result in testicular cancer or infertility. Currently, little is known about the gene 
products and signaling pathways directing these critical cell fate decisions. RA is a requisite 
driver of spermatogonial differentiation and entry into meiosis, yet the mechanisms activated 
downstream are undefined. Here, we determined a requirement for RA in the expression of KIT, 
a receptor tyrosine kinase essential for spermatogonial differentiation. We found that RA 
signaling utilized the PI3K/AKT/mTOR signaling pathway to induce the efficient translation of 
mRNAs for Kit, which are present but not translated in undifferentiated spermatogonia. Our 
findings provide an important molecular link between a morphogen (RA) and the expression of 
KIT protein, which together direct the differentiation of spermatogonia throughout the male 
reproductive lifespan. 
 
B. Introduction 
Spermatogenesis begins in the neonatal mouse testis with the transition of quiescent 
prospermatogonia into a heterogeneous population of undifferentiated and differentiated 
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spermatogonia at approximately P3-4. A subset of undifferentiated spermatogonia retain stem 
cell potential, while the rest differentiate to eventually enter meiosis as leptotene spermatocytes 
by approximately P10 (reviewed by [82, 196, 197]). It is unclear how spermatogonia make this 
critical cell fate decision, but afterwards there is a clear demarcation in the expression of specific 
proteins in undifferentiated (As-Aal) and differentiated (A1-) spermatogonia. One critical cell 
surface marker that distinguishes differentiated spermatogonia is KIT. This receptor tyrosine 
kinase is required for fertility [232-234], and has been particularly useful in the study of male 
germ cells; antibodies raised against KIT enable isolation of differentiated spermatogonia, and 
KIT expression is used to follow germ cell fate changes in transgenic and KO mice or following 
various treatments [235, 236]. KIT is bound by KITL, which is expressed by neighboring Sertoli 
cells in the seminiferous epithelium [234]. This binding activates the PI3K intracellular signaling 
pathway in spermatogonia, which is required for entry into meiosis [233, 237]. KIT is also 
essential during differentiation of a number of stem cell populations [238], including mouse 
embryonic stem cells (mESCs) [239].  
There is no consensus as to when KIT is first expressed in spermatogonia in the neonatal 
testis, although it is clear that Kit mRNA is present in undifferentiated spermatogonia and in 
prospermatogonia in the neonatal testis without detectable protein [174, 236, 240, 241]. The 
initiation of KIT protein expression in differentiating spermatogonia may involve a change in the 
utilization of Kit mRNAs. It has been clear for a long time that mRNAs are not all translated 
with equivalent efficiency [156]; those experiencing greater initiation activity recruit more 
ribosomes (polyribosomes, or polysomes) will be more efficiently translated, while those that 
initiate poorly lack ribosomes and will not produce protein. We recently assessed changes in 
mRNA translational efficiency during neonatal testis development using translation state array 
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analysis (TSAA). This is a genome-wide microarray approach in which mRNAs are identified 
based on changes in their association with polysomes (described in [242]). We identified 
approximately 3,000 mRNAs encoding both germ cell-specific and housekeeping proteins that 
become ≥2-fold enriched in polysomes in the neonatal testis from P1-4 without a significant 
change in overall mRNA abundance [158]. We found that Kit mRNAs underwent significant 
movement (approximately 5-fold) into heavy polysomes over that interval, and this provides a 
potential mechanism for the initial expression of KIT protein in spermatogonia. 
 The morphogen all-trans retinoic acid (RA) regulates the sex-specific timing of meiotic 
initiation in mice, and has been implicated in spermatogonial differentiation in the testis [54, 55, 
201-203]. Evidence supporting a role for RA in regulation of KIT expression has been largely 
gathered from in vitro experimentation. Although RA can increase Kit mRNA levels in vitro 
[149, 155, 243], this is not likely the primary mechanism regulating KIT protein production in 
vivo, as non-translating mRNA is already present in both prospermatogonia and in 
undifferentiated spermatogonia without detectable protein [174, 236, 241, 244]. We recently 
found that injection of RA into mice at P1 (prior to endogenous exposure to RA at P3-4) induced 
precocious KIT protein expression in spermatogonia [96].  
 In this study, we identify a novel mechanism by which RA regulates KIT protein 
synthesis in differentiating spermatogonia. Our results indicate that Kit mRNA translates poorly 
in the absence of RA, but becomes recruited to polysomes in response to RA in the neonatal 
testis, resulting in the first appearance of KIT protein in neonatal spermatogonia. We show that 
the first population of KIT+ spermatogonia is also STRA8+, supporting the concept that RA 
exposure is required for KIT expression. However, KIT expression is not dependent upon 
STRA8, which suggests that there are independent RA-directed pathways regulating KIT and 
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STRA8 expression. Importantly, we discovered that RA-activated PI3K and AKT signaling is 
required for induction of KIT but not STRA8. Taken together, these results suggest a novel non-
genomic pathway in which RA activates the PI3K-AKT-mTOR signaling network to regulate 
KIT expression and spermatogonia differentiation in the neonatal testis.  
 
C. Material and Methods  
C1. Animal treatments and tissue collection 
 All animal procedures were performed in accordance with the National Research Council 
Guide for the Care and Use of Laboratory Animals and approved by the Animal Care and Use 
Committee of East Carolina University (AUP #A178) and Washington State University (ASAF 
#1519). All analyses were performed using CD-1 mice (Charles River Laboratories), excepting 
Stra8-null mice, which were congenic C57Bl/6 (Griswold Lab). Administration of exogenous 
RA was done as previously described [96]. Briefly, neonatal mice received one subcutaneous 
injection of 100 µg all-trans RA (Cat# R2625, Sigma-Aldrich) dissolved in 10 µl DMSO 
(vehicle) or vehicle alone at P1, and were euthanized by decapitation 24 hours after injection (see 
Fig. 3.2A). To generate RA-deficient testes, neonatal mice received daily oral treatments of 100 
µg/g body weight WIN 18,446, suspended in 5 µl 1% gum tragacanth, for 4 days, beginning at 
birth, and were euthanized by decapitation 24 hours following the final treatment.  Vehicle 
control animals received 5 µl 1% gum tragacanth alone.  
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C2. Polysome gradient analysis 
Resolution of polysomes, ribosomal subunits, and initiation complexes was performed 
with 15-45% sucrose gradients by centrifugation as previously described [158]. Testis lysates 
from P1 and P4 mice, and mice treated with vehicle and RA were prepared as previously 
described [158]. 
 
C3. Quantitative RT-PCR 
Quantitative RT-PCR analyses were performed with RNA isolated whole testis lysate and 
with RNA from the heavy polysome fractions (fractions 9-14). RNA was isolated from P2 
prospermatogonia cultured in serum-free media for 24 hours in a previous study [115]. Fifty ng 
of RNA was subjected to reverse transcription and qPCR in the same reaction tube using iScript 
One-Step RT-PCR kit with SYBR green (BioRad). Amplification and detection of specific gene 
products were performed using the iCycler IQ real-time PCR detection system. Threshold 
temperatures were selected automatically, and all amplifications were followed by melt-curve 
analysis. Primers were designed on either side of exon junctions to avoid amplification of 
residual genomic DNA. Sequences were as follows: Rpl19 (NM_009078, 5’-
GAAATCGCCAATGCCAACTC and 5’-TCTTAGACCTGCGAGCCTCA), Stra8 
(NM_009292, 5’-GAGGTCAAGGAAGAATATGC and 5’-CAGAGACAATAGGAAGTGTC), 
Kit (NM_001122733, 5’-CATGGCGTTCCTCGCCT and 5’-GCCCGAAATCGCAAATCTTT), 
and B2m (NM_009735, 5’-CCGTGATCTTTCTGGTT and 5’-
CGTAGCAGTTCAGTATGTTCG) The following comparative quantitation equations were 
used to calculate relative mRNA levels for pooled polysomal fractions: mRNA level = (2dCT), 
where dCt = (Ct gene of interest) – (Ct min), where Ct min = the minimum Ct value within the 
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gene set and controls. For qRT-PCR on total RNA, Ct values were normalized to either B2m 
(Fig. 3.1 and 3.3) or Rpl19 (Fig. 3.2) and relative mRNA quantities were calculated by the 2ddCt, 
with dCt = (Ct untreated gene) – (Ct treated gene).  
 
C4. Immunoblotting 
Immunoblotting was performed using conventional methods. Blocking and antibody 
incubations were done in 1X PBST + 3% BSA. Primary antibodies used were against phospho-
mTOR (1:1,000, #5536, Cell Signaling Technology), phospho-EIF4EBP1 (1:1,000, #2855, Cell 
Signaling Technology), and RPS6 (1:2,000, #2217S, Cell Signaling Technology), and were 
incubated overnight at 4°C. Secondary anti-rabbit-HRP (1:3000, #7074S, Cell Signaling 
Technology) was incubated for 1 hour at room temperature. Blots were developed using 
LumiGlo detection reagent (Cell Signaling Technology).  
 
C5. Indirect immunofluorescence 
Sections from at least 4 testes from different mice were analyzed, and experiments 
performed at least thrice. Immunostaining was done using conventional methods.  Briefly, testes 
were fixed for 2 hours in 4% PFA and then washed and incubated overnight in 30% sucrose prior 
to freezing in OCT. Five µm sections were blocked for 30 minutes at room temperature and then 
incubated in primary antibody for 1 hour at room temperature or overnight at 4°C. Primary 
antibodies used were against the following: KIT (1:1000, #3074, rabbit monoclonal, Cell 
Signaling Technology) KIT (1:400, #1494, goat polyclonal, Santa Cruz Biotechnology), STRA8 
(1:3000, #49602, Abcam), ZBTB16 (1:500, #22839, Santa Cruz Biotechnology), FOXO1 (1:100, 
    
 70 
#2880, Cell Signaling Technology), and phospho-mTOR (1:50, #2976, Cell Signaling 
Technology). Primary antibody was omitted as a negative control. Following stringency washes, 
sections were incubated in secondary antibody (1:500, Alexa Fluor donkey anti-rabbit-488 or 
anti-goat-594, Invitrogen) with or without phalloidin-635 or -594 (both at 1:500, Invitrogen) for 
1 hour at room temperature. Blocking and antibody incubations were done in 1X PBS containing 
3% BSA + 0.1% Triton X-100, and stringency washes were done with 1X PBS +0.1% Triton X-
100. Coverslips were mounted with Vectastain containing DAPI (Vector Laboratories), and 
images obtained using a Fluoview FV1000 confocal laser-scanning microscope (Olympus 
America). 
 
C6. Testis explant cultures 
Testes isolated from P1 neonatal mice were detunicated, cut in thirds, and washed in 
Krebs-Ringer Bicarbonate Buffer (Sigma-Aldrich). Testis pieces were cultured in hanging drops 
with 30 µl of DMEM/F12  (Life Technology) containing 1X penicillin-streptomycin in a 
humidified incubator with 5% CO2 at 37°C. To inhibit PI3K, PDPK1, or AKT, explants were 
pretreated for 2 hours with 20 µM Ly294002 (Sigma-Aldrich), for 1 hour with 15 µM 
GSK2334470 (Tocris Bioscience), or for 2 hours with 200 µM AKT1/2 inhibitor  (Abcam, 
142088) followed by culture for 6 hours in DMEM/F12 plus vehicle and inhibitor or 10 µM RA 
and inhibitor. Controls were pretreated for 2 hours with vehicle and then cultured for 6 hours in 
vehicle or RA. Explants were then rinsed in 1X PBS and prepared for immunostaining as 
described above. 
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C7. Statistical analysis 
Statistical analyses of the qRT-PCR results were performed using the Student’s t-test, and 
the level of significance was set at P≤0.01. 
 
D. Results 
D1. KIT protein is induced in spermatogonia in the neonatal testis 
 Cell surface expression of KIT protein is a defining feature of differentiating 
spermatogonia in the neonatal, pre-pubertal, and adult testis (reviewed in [235]). However, there 
have been differing reports regarding when KIT is first detectable in neonatal spermatogonia [92, 
149, 236]. Clarification of the onset of KIT expression will help define the originating population 
of differentiating spermatogonia during the first wave of spermatogenesis. We detected KIT in 
the neonatal testis using immunostaining on cryosections. As shown previously, KIT protein was 
detectable in a subset of interstitial Leydig cells and peritubular myoid cells [245] as well as 
faintly in a small subset (6.0 ± 2.8%) of prospermatogonia in the newborn testis (Fig. 3.1A). By 
P4, prospermatogonia have transitioned to spermatogonia, and there was a dramatic increase in 
both the number of germ cells expressing KIT protein (38.6 ± 8.3%) and the intensity of the 
signal in a subset of spermatogonia (Fig. 3.1B).  
 
D2. Kit mRNA becomes more efficiently translated during spermatogonial development  
Previous studies reported the presence of Kit mRNA in undifferentiated spermatogonia 
without detectable KIT protein [174, 236]. We confirmed these results and found abundant Kit 
mRNA in isolated P2 THY1+ cell fraction enriched for prospermatogonia, as well as in whole 
testis lysates of both P1 and P4 neonatal mice (Fig. 3.1C). We determined that there was an 
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approximately 1.8-fold increase in Kit mRNA abundance in the testis from P1 to P4 (Fig. 3.1D). 
This small increase in Kit mRNA was consistent with previous microarray results [154],  and 
accompanied an approximate doubling of the germ cell population over the same interval [158]. 
Using qRT-PCR, we measured a 10.0-fold increase in Kit mRNA association with heavy 
polysomes at P4 compared to P1 (Fig. 3.1E). This robust increase in Kit mRNA translational 
efficiency accompanied the dramatic increase of KIT protein in spermatogonia at P4, but was 
only accompanied by a small increase in total Kit mRNA. Taken together, these findings indicate 
that Kit mRNAs underwent significant recruitment into polysomes to be translated during 
spermatogonia development.  
Polysome gradients were performed in collaboration with Dr. Vesna Chappell. 
 
D3. RA increases KIT protein expression in spermatogonia 
The dramatic increase in KIT protein at P4 coincided with the onset of endogenous RA 
signaling [91, 211], and RA treatment of spermatogonial cell cultures increased KIT protein 
[174]. This suggested that RA might regulate KIT protein synthesis in a similar fashion in vivo. 
Therefore, we tested the hypothesis that RA stimulated Kit translation in vivo by injecting mice 
with either vehicle or 100 µg RA at P1, approximately 2 days before endogenous RA signaling 
(Fig. 3.2A). This in vivo model of RA-activated spermatogonial differentiation induced near-
physiologic levels of Stra8 mRNA (Fig. 3.2B) [96] and induced STRA8 protein (Fig. 3.2C and 
D). In addition, exposure to exogenous RA for 24 hours increased the germ cell population by 
approximately 60% (Fig. 3.2E) [96]. 
In comparison to vehicle-treated control, there was a dramatic increase in KIT protein in 
response to RA (Fig. 3.3A and B). We next examined mRNA levels in vehicle- and RA-treated 
    
 73 
testes, and found a small 1.6-fold increase in Kit mRNA levels in response to RA (Fig. 3.3C). 
We next assessed Kit message utilization in RA-treated testes by quantifying heavy polysome-
bound Kit mRNA by qRT-PCR. RA stimulated 25-fold recruitment of Kit mRNA to heavy 
polysomes in comparison to vehicle controls (Fig. 3.3D). The precocious stimulation of Kit 
mRNA translation in response to exogenous RA resembled that affecting Kit mRNA from P1 to 
P4 (Fig. 3.1F). These results suggest a novel role for RA in stimulating translation in the 
neonatal testis.  
 
D4. KIT and STRA8 colocalize in spermatogonia in the neonatal testis 
In response to RA, the population of STRA8+ spermatogonia increased dramatically 
from P1 to P4 [91, 96, 97]. Both STRA8 and KIT are markers of differentiating/differentiated 
spermatogonia, and if both were upregulated in response to RA, then they should colocalize in 
neonatal spermatogonia. To test this, we performed co-antibody labeling against STRA8 and 
KIT on testis sections from mice aged P1 and P4. As shown above in Fig. 3.1A, KIT was faintly 
detectable in a very small subset of prospermatogonia at P1 (Fig. 3.4A), similar to results for 
STRA8 (Fig. 3.4B). A subset of spermatogonia became STRA8+ at P4 (Fig. 3.4E), and we found 
that 72% of these were also KIT+ (Fig. 3.4D and Fig. 3.4F, quantitated in Fig. 3.4M). Therefore, 
initial expression of KIT occurred predominantly in the subset of STRA8+ germ cells, 
suggesting a shared relationship to RA signaling. To further test the association of RA signaling 
and KIT protein expression, we performed co-immunostaining for STRA8 and KIT on testis 
sections from P1 mice treated for 24 h with RA. Testes treated with vehicle contained few 
STRA8+/KIT+ spermatogonia (Fig. 3.4G-I). In contrast, treatment with RA resulted in a 
dramatic increase in both KIT+ (Fig. 3.4J) and STRA8+ germ cells (Fig. 3.4K). Of these, 80% 
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were STRA8+/KIT+ (Fig. 3.4L and Fig. 3.4M). The remaining 20% of labeled cells were 
positive for one marker only, with 7% single KIT+ and 13% single STRA8+. 
 
D5. KIT expression is not dependent upon STRA8 
 STRA8 is induced in differentiating germ cells in response to RA and is required for 
fertility in both sexes [55, 63, 205]. However, despite years of study, the function of STRA8 in 
germ cell development remains unknown. Since we found KIT expression was induced by RA in 
STRA8+ germ cells, we asked whether stimulation of Kit mRNA translation was dependent 
upon STRA8 function. To address this, we injected Stra8+/- and Stra8-/- male pups [145] at P1 
with RA and assessed KIT protein expression 24 hours later. As expected, RA injection induced 
STRA8+ spermatogonia in Stra8+/- but not Stra8-/- testes (Fig. 3.5A-D). In contrast, there were 
similar numbers of KIT+ spermatogonia in testes from both Stra8+/- and Stra8 -/- pups (Fig. 3.5E-
H), demonstrating that RA-stimulated translation of Kit mRNAs was independent of STRA8 
function. 
Acquisition and RA treatment of Stra8-null testes was performed by Dr. Cathryn Hogarth. 
 
D6. KIT is not expressed in the absence of RA signaling 
Next we tested the requirement for RA in KIT protein expression by blocking RA 
synthesis in mice at P0 with WIN 18,446, an inhibitor of aldehyde dehydrogenase activity [114, 
246]. Mice were then euthanized at P4, and we observed a 33% decrease in the germ cell 
population in response to WIN 18,446 (Fig. 3.6E-G). As expected, STRA8 protein and mRNA 
were present in spermatogonia from P4 mice treated with vehicle, but absent in spermatogonia 
from mice treated with WIN 18,446 (Fig. 3.6A and B and 3.6H). Similar numbers of KIT+ 
    
 75 
Leydig and peritubular myoid cells were observed in both vehicle- and WIN 18,446-treated 
testes (Fig. 3.6C and D), indicating that RA signaling did not affect KIT expression in somatic 
cells. However, compared to controls, WIN 18,446 treatment blocked expression of KIT protein 
in spermatogonia (Fig. 3.6C and D), confirming the requirement for RA signaling in germ cell 
KIT expression. Furthermore, treatment with WIN 18,446 caused a 1.6 fold reduction in Kit 
mRNA compared to vehicle treated testes (Fig. 3.6H). This reduction in Kit mRNA is consistent 
with the small increase in Kit mRNA observed from P1-4 (Fig. 3.1D) and in response to RA 
treatment (Fig. 3.3C). Therefore, we found that inhibition of RA signaling resulted in loss of KIT 
protein expression in spermatogonia and was accompanied by only a small decrease in mRNA 
levels and did affect its expression in neighboring somatic cells. 
Dr. Cathryn Hogarth performed the WIN 18,446 treatments. 
 
D7. RA activates the PI3K-AKT-mTOR signaling pathway in spermatogonia 
 Next, we aimed to determine the mechanism by which RA stimulated the translation of 
Kit mRNAs during spermatogonial differentiation. PI3K-AKT-mTOR signaling is a common 
way by which cells regulate translation [247], and its activation is required for spermatogonial 
differentiation and entry into meiosis [248]. We adapted neonatal testis explant cultures for this 
purpose (Fig. 3.7A and B), and we can recapitulate robust STRA8 and KIT expression by 6 
hours (Fig. 3.7C and D). We tested whether RA stimulated PI3K/AKT signaling by treating 
explants with RA and assessing the localization of FOXO1, which becomes phosphorylated 
following AKT activation and relocates from the nucleus to the cytoplasm in spermatogonia 
[248, 249]. We found that FOXO1 was predominantly nuclear in vehicle-treated explants (Fig. 
3.7E), but relocated to the cytoplasm in response to RA treatment (Fig. 3.7F). We confirmed this 
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activation following in vivo RA treatment, and found increased levels of phospho-mTOR (Fig. 
3.8A). Immunofluorescence labeling revealed that these changes occurred in the cytoplasm of 
germ cells, while the signal was not detectable in Sertoli or Leydig cells (Fig. 3.8B and C).  
 To test the requirement for the PI3K-AKT signaling pathway in stimulation of KIT 
protein expression, we pharmacologically inhibited PI3K, PDPK1 (a kinase that acts downstream 
of PI3K to activate AKT and other substrates), and AKT and then treated with RA for 6 h (Fig. 
3.7B). The exclusive nuclear localization of FOXO1 following treatment with the inhibitors 
verified successful inhibition (Fig. 3.7G-H and Fig. 3.8D).  The inhibition of PI3K, PDPK1 and 
AKT followed by treatment with RA did not affect induction of STRA8 (Fig. 3.7I-J and Fig. 
3.8E) but blocked induction of KIT (Fig. 3.7I-J and Fig. 3.8E). Taken together, these results 
demonstrate that RA-induced activation of the PI3K-AKT-mTOR signaling pathway is required 
for expression of KIT. 
Testes were cultured in collaboration with Bryan Niedenberger. 
E. Discussion 
The newborn mouse testis contains an apparently homogenous population of quiescent 
prospermatogonia, which transition into type A spermatogonia after birth in the mouse. These 
type A spermatogonia either remain as SSCs or differentiate during the first wave of 
spermatogenesis. Currently, little is known about the mechanisms that control these germ cell 
fate decisions. However, it is known that RA is required for the differentiation of spermatogonia 
and their entry into meiosis [54, 55, 57, 201, 250]. In this study, we examined the relationship 
between RA signaling and expression of the receptor tyrosine kinase KIT in differentiating 
spermatogonia in the neonatal testis. We found that RA induced the recruitment of Kit mRNAs 
into polysomes for efficient translation through activation of the PI3K-AKT-mTOR signaling 
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pathway in differentiating spermatogonia. The results from this study provide a critical link 
between RA and KIT, two key determinants of spermatogonial differentiation, and demonstrate a 
novel mechanism by which RA regulates gene expression through translational control. 
There is currently a great deal of interest in determining the molecular mechanisms by 
which the mammalian SSC population is established after the initiation of spermatogenesis at 
P3-4. It is known that the undifferentiated state is maintained by signals such as GDNF, which is 
received from Sertoli cells by the subset of spermatogonia expressing the co-receptors GFRA1 
and RET [87, 110, 251]. Equally important, however, may be the avoidance of differentiation 
signals. The only known ligand-receptor interaction required for spermatogonial differentiation 
is KITL and KIT. Sertoli cells provide KITL, which is received by the subset of spermatogonia 
that express KIT. In this study, we show how RA directs expression of KIT protein, which 
provides a direct link between RA signaling and spermatogonial cell fate determination. After 
P3-4, testis cords become differentially exposed to RA [211], as shown in Fig. 3.9 by testis cord-
specific STRA8 and KIT expression. It is not clear how specific cords avoid RA exposure, 
although it may be through continuous expression of the CYP26 enzymes (predominantly 
CYP26A1 and CYP26B1), which protect prospermatogonia from RA in the fetal testis [54, 55, 
57]. The presence of an RA-free environment is likely to be a critical facilitator or determinant of 
SSC development. 
 KIT is essential for the spermatogonia transition from mitosis to meiosis [233], and KIT 
expression provides a hallmark to identify differentiated (KIT+) spermatogonia. However, it is 
currently unclear what regulatory steps direct the expression of this critical differentiation signal. 
It has been established that Kit mRNA is present in the neonatal testis and in undifferentiated 
spermatogonia without detectable protein [55, 174, 236, 241, 252, 253], and our results here 
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support those findings. It is curious that prospermatogonia and undifferentiated spermatogonia 
transcribe the Kit gene, only to prevent translation of resulting mRNAs. Importantly, KIT protein 
regulates survival, proliferation, and migration (reviewed in [254]) of male germ cells before 
(PGCs) and after (differentiated spermatogonia) those in which it is repressed (prospermatogonia 
and undifferentiated spermatogonia) [235]. It is possible that germ cells lack the requisite 
controls to alternatively activate Kit transcription in PGCs, repress it for ~1 week in 
prospermatogonia and undifferentiated spermatogonia, and then reactivate it in differentiating 
spermatogonia. A mechanism has been proposed for the repression of Kit transcription in 
spermatogonia from P7 mice through an interaction of ZBTB16 with the Kit promoter [193, 
255]. However, this is unlikely to repress Kit in the neonatal testis in vivo, as both molecules are 
co-expressed in spermatogonia through at least P6 [95, 96, 159]. 
 In the adult testis, it was recently shown that, in seminiferous tubule sections cultured in 
the presence of GDNF, Kit mRNA levels increased during specific stages II-V but did not result 
in KIT protein [252]. Interestingly, it is inferred from mRNA localization studies that these 
stages have low levels of endogenous RA exposure [136, 256]. KIT protein is then detectable in 
stages VII-VIII as spermatogonia differentiate from Aal-A1 [77, 241]. Given the results from this 
current study, it seems likely that the same mechanism of RA-induced translational control is at 
work in the adult testis in a stage-specific manner, coinciding with hypothesized cyclical changes 
in RA levels [116]. 
 RA-stimulated KIT protein expression in a subset of cultured undifferentiated 
spermatogonia was recently shown to involve the microRNAs miR-221/222 [174]. We saw a 
much more robust response in vivo, which may be due in part to the addition of growth factors to 
the culture medium such as GDNF and FGF in that study; both factors maintain SSCs in an 
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undifferentiated state [251], and may oppose endogenous mechanisms regulating normal KIT 
expression, including the upregulation of miR221/222 [174]. While it is likely that repression of 
Kit translation is regulated in part by miRNAs in vivo, they are unlikely to be the primary 
mechanism, as evidenced by the observation that SSC renewal and mitotic proliferation appear 
unaffected in the miRNA-lacking Dicer1-null mice [257], which would not be expected if KIT 
expression was largely misregulated.  
It has been known for a long time that mRNAs are not all translated with equivalent 
efficiency [156]; those that recruit more ribosomes will be more efficiently translated, while 
those that lack ribosomes will not produce protein. A recent study reported that mRNA 
translational efficiency is likely a more accurate predictor of the proteome than mRNA levels 
[258]. In accordance with this, we recently identified a large number of mRNAs that undergo 
recruitment to polysomes without significant changes in abundance during neonatal germ cell 
development [158]. This suggests that the initial differentiation of neonatal mammalian male 
germ cells may be regulated in large part by translational control.  
The most well studied action of RA is genomic, in which transcription is directed through 
RARs bound to RAREs present in the promoters of target genes such as Stra8 ([201] and Fig. 
3.9B). However, relatively modest changes in the transcriptome after RA exposure [154, 155] 
suggests other avenues of RA-based regulation may be utilized in the neonatal testis. It has 
become clear that there are also non-genomic consequences of signaling downstream of RA 
(reviewed in [195]), as with other hormone-receptor interactions, examples of which involve 
signaling through the estrogen receptor (ESR1) [259], androgen receptor (AR) [260], and 
glucocorticoid receptor (NRC31) [261]. RARA was shown in several cell types (SH-SY5Y, 
NIH3T3, and MEFs) to be bound to the regulatory subunit (p85) of PI3K; addition of RA 
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recruited the catalytic subunit (p110) to induce rapid phosphorylation of MAPK1 and AKT [189, 
190]. We provide compelling evidence here that RA-induced activation of PI3K/AKT signaling 
is required for translational control leading to production of KIT protein (Fig. 3.9D). The 
PI3K/AKT signaling network is complex, and has been shown to be involved in both self-
renewal of SSCs downstream of GDNF [111] as well as in spermatogonial differentiation 
downstream of KIT (Kissel et al. 2000). PI3K signaling is also required to maintain mESCs in an 
undifferentiated state. However, our data suggest that RA activates the mTOR signaling axis, 
which regulates translation and was not shown to regulate pluripotency in mESCs [262]. 
Together, this reveals that the PI3K-AKT signaling network interprets a variety of signals to 
direct multiple different cell fate decisions.  
Our results reveal an important link between a nearly ubiquitous morphogen (RA) and a 
molecule (KIT) that is essential for directing spermatogonial differentiation. We identify a novel 
mechanism by which RA regulates gene expression in the neonatal testis, and this discovery 
significantly advances our understanding of the molecular mechanisms controlling 
spermatogonia differentiation. 
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Fig. 3.1 KIT protein levels increase during neonatal testis development. (A and B) 
Immunostaining for KIT on mouse testis sections at P1 (A) or P4 (B). Sections were stained for 
KIT protein (green), phalloidin was added to visualize F-actin and outline the testis cords (red), 
and DAPI was added to visualize nuclei (blue). White arrows indicate KIT+ interstitial cells, and 
yellow arrows indicate KIT+ germ cells (A and B). (C) Kit amplicons from RT-PCR using total 
RNA isolated from P2 THY1+ prospermatogonia (Psg), and whole testis lysate of mice aged P1 
and P4. MW = molecular weight ladder, and NT = no template control. (D) Kit mRNA 
abundance was assessed by qRT-PCR using total testis RNA from P1 and P4 mice. (E) Kit 
mRNA abundance in heavy polysome fractions. Asterisk indicates statistical significance 
(P≤0.01). Scale bar=40 µm. 
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Fig. 3.2 RA injection induces Stra8 expression and increases the germ cell population. (A) 
Mice were injected at P1 and euthanized 24 hours later, which is 1-2 days prior to endogenous 
RA signaling. (B) Stra8 mRNA levels were assessed by qRT-PCR in vehicle- and RA-treated 
testes and compared to P1 and P4 testes. (C and D) STRA8 protein was detected (green) in testis 
sections from mice treated with the vehicle (C) or RA (D). Phalloidin was added to visualize 
testis cords (red). (E) ZBTB16+ germ cells were quantitated in testis sections from mice treated 
at P1 with the vehicle or RA. Asterisks indicate statistical significance (P≤0.01). Scale bar=40 
µm. 
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Fig. 3.3 RA stimulates KIT expression in spermatogonia by increasing mRNA utilization. (A 
and B) Immunostaining for KIT on mouse testis sections treated at P1 with vehicle (A) or RA 
(B) and euthanized 24 h later. Sections were labeled with anti-KIT (green), phalloidin was added 
to visualize testis cords (red), and DAPI stained nuclei (blue). (C) Kit mRNA levels were 
assessed by qRT-PCR from vehicle- and RA-treated mice. (D) Kit mRNA abundance in heavy 
polysomes was assessed by qRT-PCR using total testis RNA from vehicle and RA treated mice. 
Scale bar=40 µm. Asterisks indicate statistical significance (P≤0.01).  
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Fig. 3.4 KIT and STRA8 colocalize in neonatal germ cells. (A-L) Immunostaining of  mouse 
testis sections from mice aged P1 (A-C) and P4 (D-F) as well as on those from mice treated at 
P1 with the vehicle (G-I) or RA (J-L) and euthanized 24 hours later. Antibodies were used to 
detect KIT (green) and STRA8 (red), and F-actin was labeled with phalloidin (blue). Red arrows 
indicate representative KIT+ germ cells. Green arrows indicate representative STRA8+ germ 
cells, and yellow arrows indicate double KIT+/STRA8+ germ cells. (M) The number of 
STRA8+ and KIT+ germ cells were quantified in testis sections from P4 and P1 mice treated for 
24 h with RA. STRA8+, KIT+, and STRA8+/KIT+ germ cells were counted and presented as a 
percentage of labeled germ cells. Scale bar=50 µm. 
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Fig. 3.5 KIT expression is not dependent upon STRA8. Stra8+/- and Stra8-/- mice were injected 
with vehicle (A, C, E, and G) or RA (B, D, F, and H) at P1 and then euthanized 24 hours later. 
(A-H) Immunostaining was performed to detect STRA8 (A-D, green) or KIT (E-H, green). 
Phalloidin was used in each section to visualize outline of the testis cords (red). As expected, 
STRA8 and KIT were undetectable in spermatogonia in both Stra8+/- (A and E, respectively) and 
Stra8-/- (C and G, respectively) testes from vehicle-treated mice. However, RA induced STRA8 
in spermatogonia from Stra8+/- (B) but not Stra8-/- (D) mice. RA induced KIT expression in both 
Stra8+/- (F) and Stra8-/- (H) testes. Scale bar=30 µm. 
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Fig. 3.6 Loss of RA signaling prevents both STRA8 and KIT expression. (A-F) 
Immunostaining of mouse testis sections from P4 mice treated with vehicle (A, C, and E) or 
WIN 18,446 (B, D, and F). Sections were incubated with antibodies for STRA8 (A and B, 
green), KIT (C and D, green), or ZBTB16 (E and F, green). Phalloidin was added to visualize 
testis cords (in red), and nuclei were stained with DAPI (blue). Yellow arrows indicate KIT+ 
germ cells (C) and white arrows indicate KIT+ interstitial cells (C and D). (G) The total number 
of ZBTB16+ cells from E and F were determined, divided by the total cord area, and then 
multiplied by 1000 to calculate cells/mm2 and reported as a fold change from the vehicle-treated 
group. (H) Message levels for Stra8 and Kit were determined by qRT-PCR of RNA isolated 
from whole testis lysate of vehicle- or WIN 18,446-treated mice. Relative mRNA quantities were 
compared to WIN 18,446-treated samples, which were set at 1. Asterisks indicate statistical 
significance at (P<0.01). Scale bar=30 µm. 
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Fig. 3.7 RA signals through PI3K-AKT to stimulate Kit translation. (A) Model of ex vivo testis 
cultures. Testes are removed from P1 mice cut into pieces and cultured in hanging drops in the 
presence of the vehicle or RA. (B) Ex vivo testis cultures are pre-treated for 2 hours with 
inhibitors for either PI3K or AKT followed by treatment with vehicle or RA (+) the inhibitor for 
6 hours. (C-F) Immunostaining was performed on testes cultured with the vehicle or RA for 6 
hours. Sections were stained for KIT (C and D, green) and STRA8 (C and D, red) or for FOXO1 
(E and F, green). Phalloidin was added to visualize testis cords (blue in C and D, and red in E 
and F). (G-J) Testis cultures were pretreated with inhibitors of PI3K (G and I) or AKT (H and 
J) for two hours followed by co-culture with the vehicle or RA and inhibitor for 6 hours. 
Immunostaining was performed on testis sections stained for FOXO1 (G and H, green) or KIT (I 
and J, green) and STRA8 (I and J, red). Phalloidin was added to visualize testis cords (blue in G 
and H, and red in I and J). Scale bar=40 µm. 
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Fig. 3.8 RA treatment stimulates activation of mTOR. (A) Immunoblots of whole testis lysate 
from P1 testes treated with the vehicle or RA for 24 hours. Blots were probed for phospho- 
mTOR, phospho- EIF4EBP, and RPS6. (B and C) Immunostaining of P1 testes cultured in 
vehicle (B) or RA treated (C) hanging drops for six hours. Sections were probed for phospho-
mTOR (green) and phalloidin was added to visualize testis cords (red). (D and E) Testes from P1 
mice were cultured in hanging drop pretreated with an PDPK1 inhibitor followed by culture for 6 
h in the presence of RA + inhibitor. Testis sections were probed with antibodies against FOXO1 
(D, green) or co- immunostaining for KIT (green) and STRA8 (E, red). Scale bar=50 µm.  
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Fig. 3.9 RA may signal spermatogonia differentiation by activating both genomic and non-
genomic pathways. (A) Co-immunostaining was performed for KIT (green) and STRA8 (red) in 
P4 testes, and phalloidin was added to visualize testis cords (blue). Cords exposed to RA (as 
indicated by STRA8+/KIT+ spermatogonia) are circled in yellow, and those not exposed are 
encircled in white. (B) A testis cord, such as the ones shown in A, is depicted in longitudinal 
form. Regional exposure to RA would result in the differentiation of subpopulations of 
spermatogonia (yellow bands), while the other areas of the cord are unexposed so that those 
spermatogonia remain undifferentiated (white band). (C) Diagram of the canonical genomic RA 
signaling pathway, in which RA regulates transcription by binding to retinoic acid receptors 
(RAR) at retinoic acid response elements (RARE) in the promoter of target genes such as Stra8. 
(D) In the proposed alternative non-genomic pathway, RA regulates translation by binding to 
RARs, which activate the PI3K-AKT-mTOR signaling cascade to stimulate translation of 
mRNAs such as Kit. 
 
 
 
 
 
 
 
 
 
 
CHAPTER IV: MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1 
(MTORC1) IS REQUIRED FOR MOUSE SPERMATOGONIAL 
DIFFERENTIATION IN VIVO 
This chapter is modified and reprinted from Developmental Biology, (2015) 
http://dx.doi.org/10.1016/j.ydbio.2015.08.004, see Appendix F. 
 
A. Summary 
SSCs must balance self-renewal with production of transit-amplifying progenitors that 
differentiate in response to RA before entering meiosis. This self-renewal vs. differentiation 
spermatogonial fate decision is critical for maintaining tissue homeostasis, as imbalances cause 
spermatogenesis defects that can lead to human testicular cancer or infertility. A great deal of 
effort has been exerted to understand how the SSC population is maintained. In contrast, little is 
known about the essential program of differentiation initiated by RA that precedes meiosis, and 
the pathways and proteins involved are poorly defined. We recently reported a novel role for RA 
in stimulating the PI3/AKT/mTOR kinase signaling pathway to activate translation of repressed 
mRNAs such as Kit. Here, we examined the requirement for mTORC1 in mediating the RA 
signal to direct spermatogonial differentiation in the neonatal testis. We found that in vivo 
inhibition of mTORC1 by rapamycin blocked spermatogonial differentiation, which led to an 
accumulation of undifferentiated spermatogonia. In addition, rapamycin also blocked the RA-
induced translational activation of mRNAs encoding KIT, SOHLH1, and SOHLH2 without 
affecting expression of STRA8. These findings highlight dual roles for RA in germ cell 
development – transcriptional activation of genes, and kinase signaling to stimulate translation of 
repressed messages required for spermatogonial differentiation.  
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B. Introduction 
RA is required for inducing both spermatogonial differentiation and subsequent entry into 
meiosis [54, 55]. After birth in the mouse, subsets of spermatogonia begin to differentiate in 
response to RA at approximately P3-4, as indicated by their expression of STRA8 and KIT [91, 
95, 96, 211]. However, germ cells do not enter meiosis in response to RA until approximately 
P10 [116]. This reveals that the processes of differentiation and meiotic entry are temporally 
separated by approximately 7 days in the neonate (which lengthens to 8.6 days in the adult). It 
has been proposed that the reduced time in the neonate may be because some of the steps are 
skipped or because cell proliferation is accelerated by the increased temperature at which 
spermatogenesis proceeds in the neonate (37°C in neonates versus 33°C in adults) [74]. During 
this approximately week-long differentiation period, type A1 spermatogonia successively become 
type A2, A3, A4, In, and B before entering meiosis as preleptotene spermatocytes [70, 250, 263]. 
Spermatogonia apparently cannot be induced to precociously enter meiosis in response to 
exogenous RA [95, 96, 188], which implies that these sequential spermatogonial divisions are 
required. However, little is known about the cellular processes that must occur or the molecular 
pathways that regulate them in differentiating spermatogonia prior to meiotic initiation. 
A primary reason for this lack of knowledge is that there are few changes in steady-state mRNA 
levels during differentiation [153-155]. Without dramatic changes in the transcriptome, scientists 
have lacked identified targets (pathways, proteins) for focused studies. 
A number of recent genome-wide studies have revealed that the transcriptome 
imperfectly predicts the proteome (estimates range from approximately 40-80% agreement) 
[258, 264, 265], and there is likely to be considerable variation in this level of disconnect in 
different cell types and under different conditions. Our previous studies suggest that a majority 
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of gene expression changes required for spermatogonial differentiation occur at the 
posttranscriptional level [157, 158]. We previously showed that RA treatment leads to increased 
phosphorylation of the master regulatory kinase mTOR [157], indicating it is activated in 
differentiating spermatogonia. This is accompanied by enhanced translation of repressed Kit 
mRNAs through activation of the PI3K/PDPK1/AKT signaling network [157, 159]. MTOR 
exists in functionally distinct protein complexes (mTORC1 and mTORC2), which integrate 
numerous cues to regulate, in broad terms, cellular growth and differentiation (mTORC1) or the 
actin cytoskeleton and insulin signaling (mTORC2) (reviewed by [191, 192, 266-268]). A 
primary role of mTORC1 is to regulate cap-dependent mRNA translation initiation, which is the 
rate limiting and regulated step of eukaryotic protein synthesis. MTORC1 performs this function 
in part by phosphorylating downstream targets EIF4EBP1 and RPS6KB1/2. Enhanced 
phosphorylation of EIF4EBP1 by activated mTOR releases EIF4E to associate with the 5’-cap of 
mRNAs, thus allowing recruitment of translationally controlled mRNAs to ribosomes, 
particularly during germ cell differentiation in lower organisms [160, 161, 181, 269, 270]. 
Activated RPS6KB1/2 phosphorylates the 40S ribosomal subunit RPS6, leading to activation of 
ribosomes and enhanced mRNA translation. This activity is essential for the translational control 
of the TOP mRNAs, which have 5’ oligopyrimidine tracts, are activated by changes in cellular 
metabolism, and often encode components of the translational machinery [271, 272].  
The mTOR complexes differ in their sensitivity to rapamycin, a macrolide antifungal 
compound originally isolated from the soil bacterium Streptomyces hygroscopicus that has an 
expanding number of clinical uses. Rapamycin acutely inhibits mTORC1 activity, but has also 
been shown to inhibit mTORC2 in some contexts following prolonged exposure [266, 273, 274]. 
The effects of rapamycin vary significantly depending on the cell type involved. Some cell types 
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appear to be quite rapamycin-insensitive, while others slow or cease proliferating, fail to 
differentiate, and/or undergo apoptosis [247, 266, 267]. This has been suggested to be due in part 
to differential effects on downstream substrates such as EIF4EBP1 and/or RPS6KB1/2 [276]. 
Rapamycin can be administered in vivo, and actually extends the lifespan of lower organisms and 
mice ([277, 278], reviewed in [267, 275]). In addition, studies have suggested a link between 
mTORC1 and spermatogonial cell fate regulation both in vitro and in vivo [157, 158, 193, 279-
281].  
Studying the effects of mTORC1 inhibition by rapamycin has direct relevance for human 
male reproductive health. Rapamycin analogs (Sirolimus and Everolimus) are currently used to 
reduce cellular proliferation as part of immunosuppressive and chemotherapeutic regimens given 
to organ transplant, cardiology, and cancer patients [266, 267, 282-287]. These drugs can cause 
reversible human male infertility with unclear etiology (reviewed by [288-291]). Specifically, 
rapamycin analog treatments caused a block in spermatogonial differentiation in a human patient 
[292] as well as in a study using rats, although no detailed analyses were performed [293]. Both 
treated humans and rats exhibit reduced testosterone levels due to inhibition of the hypothalamic-
pituitary-gonadal axis. However, this may not cause a defect in spermatogonial differentiation, 
but rather in progression through meiosis, at least in rodents [294]. Infertility is a significant 
quality of life concern for reproductive-aged male organ transplant and cancer patients, and to-
date no comprehensive studies have explored the mechanism of action of mTOR inhibition 
during spermatogenesis.  
Here, we examine the effects of rapamycin-mediated mTORC1 inactivation on 
spermatogonial differentiation in vivo in the mouse. Our results reveal that mTORC1 activation 
is dispensable for the maintenance of undifferentiated spermatogonia, but that it is required for 
    
 103 
spermatogonial proliferation and differentiation prior to meiotic initiation. In addition, we find 
that rapamycin inhibition of mTORC1 blocks the RA-induced translation of repressed mRNAs 
encoding KIT, SOHLH1, and SOHLH2, which are essential regulators of spermatogonial 
differentiation. However, rapamycin treatment did not block the expression of STRA8, a direct 
transcriptional target of RA. This reveals that spermatogonia exhibit dual responses to RA in the 
form of transcriptional activation and kinase signaling-enhanced translation of repressed 
mRNAs. In addition, these results provide critical insight into the male infertility that can result 
as an adverse side effect of the clinical use of rapamycin analogs. 
 
C. Material and Methods 
C1. Animal treatments and tissue collection 
All animal procedures were performed in accordance with the National Research Council 
Guide for the Care and Use of Laboratory Animals and approved by the Animal Care and Use 
Committee of East Carolina University (AUPs #A178a and #A193). Analyses were done using 
CD-1 mice (Charles River Laboratories) or Id4-GFP mice, which are on a C57Bl/6 background 
[153]. Rapamycin was dissolved in DMSO (vehicle) and then diluted to a final concentration of 
5 µg / µl in a solution of 5% polyethylene glycol 400 (Sigma-Aldrich) and 5% polysorbate 80 
(Sigma-Aldrich). Rapamycin was fed daily using a 24-gauge feeding needle, in two regimens: 1) 
from P1-3 and then euthanized at P4 or 2) from P1-7 and then euthanized at P8. Using dosages 
similar to a previous study [295], we fed CD-1 mice rapamycin at 20 µg/g body weight, and Id4-
GFP mice received 10 µg/g. The administration of exogenous RA was done as previously 
described [96]. Briefly, neonatal mice received one subcutaneous injection of 100 µg all-trans 
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RA (#R2625, Sigma-Aldrich) dissolved in 10 µl DMSO (vehicle) or vehicle alone at P3, and 
were euthanized by decapitation 24h later.  
 
C2. Polysome gradient analysis 
 Polysome gradients were performed as previously described [158]. Briefly, total testis 
lysates from at least 22 P4 vehicle- or rapamycin-treated mice were loaded onto 15%-45% linear 
sucrose gradient in polysome lysis buffer (100 mM KCl, 5 mM MgCl
2
, 10 mM HEPES pH 7.4, 
0.5% NP-40, and 100 µg/ml cycloheximide). Gradients were fractionated, and 14 successive 
fractions were collected. RNA was isolated using TRIzol reagent based on manufacturer’s 
protocol from pooled heavy polysome fractions (9-14).  
 
C3. Quantitative RT-PCR 
QRT-PCR was performed in triplicate on total RNA isolated from pooled polysomal 
fractions and on RNA isolated from whole testis lysates from at least 3 different mice as before 
[157, 158]. Briefly, generation of cDNA and amplification were performed in the same reaction 
tube using One-Step SYBR green and iScript polymerase (Bio-Rad) in an Applied Biosystems 
ViiA 7 Real-Time PCR System (Life Technologies). Primers were designed to span introns for 
Kit, Sohlh1, Sohlh2, Stra8, and B2m (Table 4.1). QRT-PCR was performed to measure the 
abundance of specific mRNAs within whole testis total RNA. Fold changes were calculated 
using the delta-delta Ct (ddCt) method using the reference gene B2m. Polysome occupancy of 
specific mRNAs was determined using qRT-PCR to amplify RNA isolated from pooled 
polysomal fractions. Relative mRNA levels were assessed using the dCt method from the lowest 
Ct in the group, and reported as a fold change.  
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C4. Indirect Immunofluorescence  
Immunostaining was performed as previously reported. Briefly, testes from at least 3 
different mice were fixed in 4% PFA at 4°C. Testes were embedded in OCT, frozen, and cut into 
5 µm sections. Sections were incubated with primary antibodies (see Table 4.2) for 1h at room 
temperature. Following stringency washes, sections were incubated with either Alexa Fluor anti-
goat or anti-rabbit secondary antibody (1:2,000, Invitrogen) and phalloidin-635 or -594 (1:1,000, 
Invitrogen). Coverslips were mounted with Vectastain containing DAPI (Vector Laboratories). 
Images were captured using a Fluoview FV1000 confocal laser-scanning microscope (Olympus 
America). 
 
C5. Cell Quantitation 
Immunostaining was performed on 5 µm frozen testis sections. Quantitation was carried 
out as previously described [95] and immunostaining was performed for DDX4 to mark all 
prospermatogonia and spermatogonia in the neonatal testis. Germ cells within 21-30 testis cords 
were counted from 3 different animals. Cells were identified as positive for a marker if selected 
by the threshold tool in Image J (U.S. National Institutes of Health) using the default algorithm. 
Intensity thresholds were as follows: DDX4 = 100-255, KIT = 40-255, SOHLH1 = 90-255, 
SOHLH2 = 90-255. Testis sections from Id4-Gfp mice were immunostained with anti-DDX4 
antibodies. Photomicrographs were captured with an Axio Observer A1 microscope (Carl Zeiss 
Microscopy) equipped with an XL16C digital camera and Exponent version 1.3 software (Dage-
MTI). Bright Id4-GFP+ cells were selected by Image J software with intensity thresholds set at 
0-60. At least 400 DDX4+ cells were selected from 4 testis sections, and the number of GFP-
bright cells recorded. Testes were analyzed from at least 3 mice.  
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C6. Statistical analysis 
Statistical analyses of the qRT-PCR results and cell counts were performed using 
Student’s t-test, and the level of significance was set at p≤0.01. 
 
D. Results 
D1. Rapamycin treatment reduces testicular size and arrests germ cell development 
Our previous study revealed that RA activated the PI3K/AKT kinase signaling network in 
differentiating spermatogonia [157]. This also resulted in phosphorylation (implying activation) 
of mTOR, which acts in mTORC1 to direct cellular growth, proliferation, and differentiation 
(reviewed in [266]). Here, we addressed the requirement for mTORC1 in spermatogonial 
differentiation in vivo by feeding vehicle alone or rapamycin to neonatal mice once daily 
beginning at P1, which is 2-3 days prior to the onset of normal differentiation. Mice were then 
euthanized at P4 and P8 (Fig. 4.1A), and testes were harvested for various analyses. Although 
animals appeared healthy, there was a significant decrease in body weight and testis size and 
weight in response to rapamycin treatment at both P4 and at P8 (Fig. 4.1C and D). Testis weights 
were normalized to total body weight and there were 26% and 31% decreases at P4 and P8, 
respectively (Fig. 4.1E). Since reduced testis weight often results from reduced cellularity, we 
examined Bouin’s-fixed testis sections stained with H&E from vehicle- and rapamycin-treated 
mice. Germ cell types in the neonatal testis are readily distinguished based on their characteristic 
size, location, and nuclear morphology [68-70]. Vehicle-treated control testes from P4 and P8 
mice had the germ cells at the expected stages of development  (Fig. 4.1G and I) [68, 263, 296, 
297]. At P8, there were abundant spermatogonia and preleptotene spermatocytes and a small 
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number of meiotic leptotene spermatocytes. In contrast, rapamycin-treated P8 testes had 
significantly reduced testis cord diameters (Fig. 4.1F) and many fewer germ cells, with the most 
advanced stage resembling undifferentiated spermatogonia (Fig. 4.1H and I).  
 
D2. Rapamycin inhibits mTORC1 activity in spermatogonia 
Before carefully examining the phenotype of rapamycin-treated testes, we verified that 
rapamycin treatment inhibited mTORC1 activity as expected. We examined the phosphorylation 
of mTOR as well as RPS6, which is an indirect target downstream of activated mTORC1. There 
was a near-complete loss of p-mTOR and p-RPS6 in response to rapamycin (Fig. 4.2A-D). We 
recently reported that RA caused a dramatic nuclear-to-cytoplasmic relocalization of FOXO1 
[157], which is indicative of AKT activation [248, 249]. Since this signaling step is generally 
upstream of mTOR phosphorylation, we hypothesized that rapamycin inhibition would not alter 
FOXO1 localization.  Indeed, there was no appreciable difference in the ratios of cytoplasmic: 
nuclear FOXO1 in vehicle- or rapamycin-treated germ cells (Fig. 4.2E and F). Therefore, we 
conclude that rapamycin treatment inhibited mTORC1 activation in spermatogonia without 
affecting upstream activation of signaling components such as AKT, which implies that 
mTORC2 signaling was not perturbed. 
 
D3. Undifferentiated spermatogonia accumulate in rapamycin-treated testes 
Rapamycin treatment from P1-4 and P1-8 resulted in an apparent reduction in germ cells 
(Fig. 4.1H and J). We quantified this in vehicle- and rapamycin-treated mice by immunostaining 
for DDX4, a pan germ cell marker in the neonatal testis. There were reduced numbers of DDX4+ 
germ cells at P4 (-1.63±0.03-fold) and P8 (-2.74±0.04-fold) (Fig. 4.3A-D, M and N). The 
    
 108 
decreased number of germ cells could result from a rapamycin-induced increase in apoptosis, 
although we did not see evidence for this in H&E-stained sections (Fig. 4.1G-J, data not shown). 
We nonetheless assessed this possibility by immunostaining for cleaved PARP1, an accepted 
marker for apoptotic cells. As expected, there was no significant increase in cleaved-PARP1+ 
cells in rapamycin-treated testes at P4 or P8 (P1-4 vehicle-treated = 0.17±0.06 cleaved-PARP1+ 
cells/testis cord, P1-4 rapamycin-treated = 0.13±0.06 cleaved-PARP1+ cells/testis cord, Fig. 
4.3E-H), indicating that apoptosis was not responsible for the reduced germ cell numbers. We 
next assessed whether there was a reduction in germ cell proliferation in response to rapamycin. 
We first immunostained using an antibody against MKI67, which marks actively proliferating 
cells in all stages of the cell cycle except in G0 [298, 299]. There was no difference in MKI67 
staining at P4 in response to rapamycin treatment. However, there were significantly fewer 
MKI67+/DDX4+ cells at P8 in rapamycin treated testes. (-1.85±0.37-fold, Fig. 4.4A-E). We next 
injected vehicle- and rapamycin-treated mice with BrdU 10h prior to euthanasia on P4 and P8. 
There were ≈1.9-fold fewer BrdU+ germ cells in response to rapamycin at P4 and P8 (Fig. 4.3I-
L, O and P). We also assessed effects of rapamycin on Sertoli cell numbers by immunostaining 
for the Sertoli cell marker GATA4, and found that there was no appreciable change at P4 (P1-4 
vehicle = 18.3±0.6 GATA4+ cells/testis cord, P1-4 rap-treated = 19.67±3.3 GATA4+ cells/testis 
cord) or P8 (P1-8 vehicle = 18.8±4.0 GATA4+ cells/testis cord, P1-8 rap-treated = 17.1±15.5 
GATA4+ cells/testis cord, Fig. 4.5). Therefore, we conclude that rapamycin inhibited germ cell 
proliferation without increasing apoptosis or changing Sertoli cell numbers. 
Immunostaining and cell quantitation used in this section was performed in collaboration with 
Bryan Niedenberger. 
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We next tested whether mTORC1 inhibition by rapamycin prevented the normal 
differentiation of spermatogonia. Based on the apparent accumulation of undifferentiated 
spermatogonia at P4 and P8 in response to rapamycin (Fig. 4.1H and J), it appeared that 
spermatogonial differentiation was blocked by rapamycin treatment. We assessed whether 
spermatogonia upregulated markers of differentiation (KIT, SOHLH1, and SOHLH2) in the 
absence of mTORC1 function. Each marker was readily detectable in spermatogonia in vehicle-
treated testes at P4 (Fig. 4.6A, C, and E). In contrast, KIT, SOHLH1, and SOHLH2 were barely 
detectable in a few spermatogonia in rapamycin-treated testes (Fig. 4.6B, D, and F). The absence 
of differentiation markers suggests that the germ cells remained in an undifferentiated state in the 
absence of mTORC1 activity. We tested this by immunostaining for GFRA1, an established 
marker of undifferentiated spermatogonia, which together with RET forms the receptor for 
GDNF [110, 251]. We found that at P8 66% of DDX4+ spermatogonia were GFRA1+ in 
response to rapamycin, which represented a 5.1-fold increase over vehicle-treated controls  (Fig. 
4.7A-C). We further explored this using a recently created transgenic mouse line, in which the 
SSC population is marked by the expression of GFP under the control of the Id4 promoter [153]. 
Recent work has demonstrated that SSC activity resides within the Id4-GFP+ cell population 
[153]. To test if treatment with rapamycin affects formation or size of the SSC population, we 
treated Id4-GFP pups with vehicle or rapamycin from P1 through P7 and euthanized them on P8. 
The results demonstrated that 19% of the total germ cell population was GFP-bright in both the 
vehicle- and rapamycin-treated testes (Fig. 4.7D-F), indicating that the size of the SSC pool was 
not affected by mTORC1 inhibition. 
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D4. Rapamycin blocks RA-enhanced translation of repressed mRNAs 
Finally, we investigated how KIT, SOHLH1, and SOHLH2 protein levels were 
dramatically reduced following inhibition of mTORC1. We previously found that mRNAs for 
Kit, Sohlh1, and Sohlh2 became associated with heavy polysomes at P4 [158], which coincided 
with the appearance of detectable protein. In a separate study, we reported that RA activated 
translation of repressed Kit mRNAs during differentiation by inducing heavy polysome 
occupancy without a dramatic increase in their abundance [157]. We therefore examined whether 
Sohlh1 and Sohlh2 mRNAs were regulated similarly in response to RA. In response to RA, both 
SOHLH1 and SOHLH2 protein levels increased dramatically (Fig. 4.8A, B, D, and E), and as 
previously shown, RA treatment also induced Kit translation (Fig. 4.8G and H, [96, 157]). This 
increase in protein was not accompanied by an increase in steady-state mRNA levels (Fig. 4.8C, 
F, and I). We then performed polysome gradient analysis to test whether RA induced Sohlh1 and 
Sohlh2 mRNA heavy polysome occupancy for efficient translation, as we recently showed for 
Kit [157]. Polysome gradients allow for the fractionation of mRNAs based on their association 
with ribonucleoprotein particles, ribosome subunits, and light and heavy polysomes. The 
identification of specific mRNAs within sedimenting fractions reflects their translational 
efficiency, with those in heavy polysomes being most efficiently translated (reviewed in [300]). 
We pooled heavy polysome fractions in testes from vehicle- and RA-treated mice and discovered 
that Sohlh1, Sohlh2, and Kit mRNAs became enriched in heavy polysomes in response to RA 
(Fig. 4.8C, F, and I). We conclude that, like Kit, Sohlh1 and Sohlh2 mRNAs are not efficiently 
translated in undifferentiated spermatogonia, and become activated at the level of translation in 
response to RA.  
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We next examined whether rapamycin treatment would inhibit this RA-induced 
translational activation. We utilized P4 rapamycin-treated testis, as they contained more similar 
numbers of germ cells to vehicle-treated controls than at P8 (Fig. 4.3A-D). In response to 
rapamycin, there was a small but statistically significant decrease in steady-state mRNA levels 
for Sohlh1, Sohlh2, and Kit (Fig. 4.9A-C), which corresponded closely with the decrease in the 
germ cell population at P4 (Fig. 4.3A-B). We found that rapamycin treatment caused a 
significant decrease in polysome occupancy for each of these mRNAs in comparison with 
vehicle-treated controls (Fig. 4.9A-C).  
The QRT-PCR was performed in collaboration with Ellen Velte. 
Lastly, because rapamycin treatment could affect other cells in the testis and reduce 
endogenous RA levels, we tested whether exogenous RA could induce STRA8 a known 
transcriptional target required for meiotic initiation [91, 96, 145, 146, 205], in testes of 
rapamycin-treated mice. We assessed this using testes from mice euthanized at P4 following 
treatment with vehicle or rapamycin from P1-4 and injected with RA at P3 (Fig. 4.9D).  We 
found that RA induced STRA8 and KIT in vehicle-treated control testes, as expected (Fig. 4.9E). 
In rapamycin-treated testes, KIT was not induced, as shown above (Fig. 4.6F and Fig. 4.9F). 
However, STRA8 was induced in response to RA. As expected, exogenous RA treatment 
induced Stra8 mRNA in rapamycin-treated testes (Fig. 4.9G). This indicates that RA activates 
expression of STRA8 and KIT in spermatogonia through distinct mechanisms (mTORC1-
independent for STRA8, mTORC1-dependent for KIT). Taken together, results from the current 
study indicate that mTORC1 activation is a critical step downstream of RA in the translational 
activation of essential regulators of spermatogonial differentiation such as KIT, SOHLH1, and 
SOHLH2. 
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E. Discussion 
Here, we show that inhibition of mTORC1 activity in the testis by rapamycin has 
profound effects on spermatogonial development. Rapamycin inhibited spermatogonial 
proliferation and differentiation, which reduced the germ cell population overall, but increased 
the percentage of undifferentiated spermatogonia (GFRA1+) and did not affect the SSC pool 
(Id4-GFP bright cells). At the molecular level, we found that rapamycin changed the 
spermatogonial response to RA. While Stra8 mRNA and protein were still induced in 
rapamycin-treated testes in response to RA, the enhanced translation of Sohlh1, Sohlh2, and Kit 
mRNAs was blocked. This supports the concept that RA exerts dual roles in the activation of 
transcription and translation in spermatogonia, and that blocking mTORC1 activation can 
functionally decouple these actions. Altogether, our results reveal an essential role for mTORC1 
activation in RA induced enhanced translation of genes required for spermatogonia proliferation 
and differentiation, and provide insight into the male infertility phenotype observed following 
administration of rapamycin to both rodents and humans. 
Rapamycin has wide-ranging cell- and tissue-specific effects. In animal models, 
rapamycin can exert a variety of positive consequences including lifespan extension, reduction of 
cancer progression, improved organ transplant retention, neuroprotection from damage caused by 
diseases such as Alzheimer’s, Huntington’s, and Parkinson’s, and suppression of high fat diet-
induced obesity (reviewed in [267]). These diverse outcomes highlight the observations from 
many laboratories that the molecular signaling through mTORC1 varies in a cell-dependent 
context. In particular, mTORC1 inhibition can alternatively lead to reduced proliferation, 
increased apoptosis, and blocked cellular differentiation (reviewed in [266]). In this study, 
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treatment with rapamycin prior to the onset of differentiation (at P3-4) did not result in germ cell 
loss by apoptosis, but rather a near-complete inhibition of differentiation such that no cells were 
seen preparing to enter meiosis as preleptotene spermatocytes at P8. Our results also indicate that 
Sertoli cell numbers were unaffected by the treatment, and there were no significant changes in 
their position or appearance. The prolonged exposure to rapamycin can also inhibit the function 
of mTORC2, although this varies widely with cell type [301]. This is not likely occurring in this 
study; since activated mTORC2 phosphorylates and activates AKT [302], we would expect that 
its inhibition would lead to an increase in cytoplasmic FOXO1, which we did not observe.  
During differentiation, spermatogonia respond to RA by proliferating and undergoing 
largely unknown cellular changes that precede meiosis. A primary reason for this lack of 
knowledge about spermatogonial differentiation is that there are very few changes in steady-state 
mRNA levels between undifferentiated and differentiating spermatogonia [153-155]. Without 
dramatic changes in the transcriptome, scientists have lacked targets (pathways, proteins) for 
focused studies. The classic mechanism by which RA controls gene expression is through 
modulating transcription of RA-responsive genes such as Stra8 and Rec8, which are required for 
entry into and progression through meiosis [145, 147, 205, 303]. Here and in a previous report 
[157], we identify a novel mechanism by which RA signals through the PI3K/AKT/mTOR 
signaling pathway to initiate the efficient translation of mRNAs required for spermatogonia 
differentiation. This reveals that RA can regulate gene expression by multiple mechanisms. In 
addition to Kit, we report here that the mRNAs for Sohlh1 and Sohlh2, which also encode 
essential determinants of spermatogonial differentiation, are stimulated by RA to become 
recruited into polysomes, resulting in a dramatic increase in protein levels without significant 
increases in steady-state mRNA abundance. This discrepancy between abundant mRNA and 
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undetectable or barely detectable protein was previously alluded to in studies from the Rajkovic 
laboratory [144, 304]. Additional evidence for the transcription of these genes in undifferentiated 
spermatogonia comes from whole tubule explant cultures, in which GDNF increased mRNA 
levels for both Kit and Sohlh1, but did not induce protein expression [252]. Therefore, it is 
possible that a subset of genes is transcribed in undifferentiated spermatogonia, and that these 
mRNAs are poorly translated until RA activates the PI3K/AKT/mTOR kinase-signaling pathway 
to direct their mobilization into heavy polysomes for efficient translation. Our data supports a 
model whereby mTORC1 activation by RA leads to the translational activation of specific 
mRNAs required for spermatogonial differentiation (Fig. 4.10). There is precedent for a similar 
posttranscriptional regulation downstream of RA in local translation at neuronal dendritic and 
axonal termini. In that paradigm, RA binds RARA to activate the PI3K/AKT signaling pathway 
and stimulate translation of repressed mRNAs including Gria1/Glur1 [190, 305-308]. 
Furthermore, a study found using the F9 cell line that RARG associated with the p-85 regulatory 
subunit of PI3K, and that PI3K-AKT activation by RA was required for F9 cell differentiation 
[189, 190].  
It is clear that certain mRNAs are exceedingly sensitive to translational suppression by 
rapamycin [309]. These disproportionately affected mRNAs may have a stronger reliance on 
cap-dependent translation. Previous studies have shown that mTORC1-sensitive mRNAs 
generally contain complex 5’ UTRs that are positively regulated by phosphorylation of 
EIF4EBP1 [192] or are members of the class of 5’ TOP mRNAs which contain a 5’ terminal 
oligopyrimidine tract [310]. It is clear that Kit, Sohlh1, and Sohlh2 mRNAs appear to be sensitive 
to translational repression during spermatogenesis in vivo. This effect is mimicked by mTORC1 
inhibition. Future studies will be aimed at identifying features within the UTRs that regulate 
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translational repression and activation during spermatogenesis. 
Germ cells are exposed to high levels of RA within discrete segments of the seminiferous 
cords (in the neonate and juvenile) and tubules (in the adult). In the adult, RA levels are highest 
along the seminiferous tubules at stages VII-VIII of the epithelial cycle [151]. This provides an 
explanation for how RA can regulate three distinct events simultaneously in different cell types, 
as they all occur at these stages: differentiation of type Apr and Aal into A1 spermatogonia, 
meiotic initiation of preleptotene spermatocytes, and spermiation of condensed spermatids. 
Indeed, RA has been shown to be required for each of these processes (reviewed in [146, 201, 
263, 311]).  
One interesting point to consider is that, although RA is required for the initiation of 
spermatogonial differentiation (to A1 spermatogonia), the subsequent divisions (A2, A3, A4, In, 
B) occur in levels of low or absent RA [151]. It is possible, then, that an important role of RA in 
spermatogonia is to stimulate the translation of mRNAs encoding KIT, which binds KITL to 
signal through the same PI3K/AKT/mTOR signaling pathway in spermatogonia in culture [233, 
279]. By doing so, RA may signal through PI3K/AKT initially, and then the newly synthesized 
KIT receptor will bind KITL and maintain mTORC1 activation during these later differentiation 
stages when levels of RA are low or absent. This scenario would explain how the mRNAs for 
Kit, Sohlh1, and Sohlh2 would remain efficiently translated despite low levels of RA. 
Previous studies have suggested a role for mTORC1 in spermatogonial fate 
determination. In the first study, rapamycin blocked proliferation (incorporation of BrdU) in 
cultured spermatogonia and prevented KITL-induced phosphorylation of RPS6KB1, suggesting 
that PI3K/AKT signaling was required in vivo [279]. In the second study using spermatogonia 
isolated from juvenile mice, it was concluded that ZBTB16 repressed mTORC1 activity by 
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maintaining modestly higher steady-state mRNA levels (approximately 3-fold) of an indirect 
negative regulator, DDIT4 [193]. However, it was recently reported that Ddit4-null mice are 
viable and fertile, with no apparent defects in spermatogenesis [194]. In addition, 
proliferating/differentiating mTORC1-active neonatal spermatogonia contain abundant ZBTB16 
[95], suggesting this model does not fully explain mTORC1 regulation in differentiating 
spermatogonia in vivo. In a third study, rapamycin was administered to adult testis tubules 
maintained in hanging drop cultures for 24h [312]. As expected, this reduced levels of p-mTOR, 
p-RPS6KB1, and p-EIF4EBP1 in spermatogonia and preleptotene spermatocytes. In addition, 
steady-state levels of PCNA and STRA8 were reduced, although these were assessed by western 
blot analysis of whole tubule lysates [312]. Since STRA8 levels are highest in preleptotene 
spermatocytes within stage VIII tubules [91, 151, 188], it is unclear whether the reduction in 
STRA8 protein levels following short-term rapamycin treatment was from impaired expression 
in spermatogonia (implying impaired differentiation) or in preleptotene spermatocytes. In a 
fourth study, Hobbs and colleagues generated germ cell Tsc2-null mice, which encodes an 
indirect repressor of mTORC1 activation. Therefore, Tsc2-null germ cells would be predicted to 
have elevated mTORC1 activity. When Tsc2 was deleted beginning in fetal prospermatogonia 
(by Ddx4-Cre), there were fewer undifferentiated spermatogonia (ZBTB16+), and an increased 
number of atrophic tubules in the adult. However, this incomplete effect suggests that loss of 
TSC2 either did not increase mTORC1 activation in all undifferentiated spermatogonia, or that a 
subset of spermatogonia differ in their response to mTORC1 activation. Here, we did not see a 
change in the Id4-GFP+ SSC-containing population in response to rapamycin treatment, which 
indicates that mTORC1 activity is low or not required in SSCs. Hobbs et al found that Tsc2 
deletion in differentiating spermatogonia (using Stra8-Cre deletion), resulted in no discernable 
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phenotype, presumably because mTORC1 was already activated in these differentiating cells. 
Taken together, those results complement our findings here that mTORC1 is suppressed in 
undifferentiated spermatogonia, and that its activation is necessary for differentiation.  
In summary, this study provides the first examination of the requirement for mTORC1 
activation in spermatogonial differentiation in vivo. Our results indicate that inhibition of 
mTORC1 blocked the RA-induced translational activation of repressed mRNAs, repressed 
spermatogonial differentiation, and resulted in an accumulation of undifferentiated progenitor 
spermatogonia.  
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Figure 4.1 MTORC1 inhibition blocks spermatogonial differentiation. (A) Experimental 
design for treating mice with rapamycin in vivo. Mice were treated with vehicle or rapamycin 
once daily starting at P1 and euthanized 24h after last treatment at P4 or P8. (B) Representative 
images of testes from vehicle (left) and rapamycin (right) treated mice euthanized at P4 (top) and 
P8 (bottom). (C-E) Mice treated with vehicle or rapamycin were euthanized at P4 or P8. Prior to 
euthanasia total body weights were collected (C), following euthanasia total testis weights were 
collected (D). Testis weights were normalized to body weights and expressed as a ratio (E). (F) 
Quantitation of testis cord diameter of mice treated with vehicle or rapamycin and euthanized at 
P4 or P8.  (G-J) H&E staining of mice treated with vehicle (G and I) or rapamycin (H and J) 
and euthanized at P4 (G and H) or P8 (I and J). Yellow arrows indicate spermatogonia, and 
green and orange lines encircle preleptotene and leptotene spermatocytes, respectively (I). Scale 
bar=40 µm. Asterisks indicate statistical significance (P<0.01). 
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Figure 4.2 Treatment with rapamycin inhibits mTORC1 activity without affecting AKT. (A-F) 
Immunostaining of testis sections from mice treated with vehicle (A, C, and E) or rapamycin (B, 
D, and F) and euthanized at P4. Sections were stained with anti- phosphorylated mTOR (A and 
B), anti- phosphorylated RPS6 (C and D), or total FOXO1 (E and F). F-actin was stained with 
phalloidin (red) to visualize testis cords. Scale bar=50 µm. 
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Figure 4.3 MTORC1 is required for postnatal expansion of the germ cell population. (A-L) 
Immunostaining of testis sections from mice treated with vehicle (A, C, E, G, I, and K) or 
rapamycin (B, D, F, H, J, and L) and euthanized at P4 (A, B, E, F, I, and J) or P8 (C, D, G, H, 
K, and L). Sections were stained with anti-DDX4 (A-D), anti-cleaved PARP1 (E-H), or double 
labeled with anti-BrdU (green, I-L) and anti-DDX4 (red, I-L). F-actin was stained with 
phalloidin (red, A-D or blue, E-H). Quantitation of the number of DDX4+(M and N) or the 
number of BrdU+/DDX4+ (O and P) cells from testes treated starting at P1 with vehicle or 
rapamycin and then euthanized at P4 (M and O) or at P8 (N and P). Scale bar=50 µm. Asterisks 
indicate statistical significance (P≤0.01). 
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Figure 4.4 Inhibition of mTORC1 does not induce spermatogonial quiescence. 
Immunostaining of testis sections from mice treated with vehicle (A and C) or rapamycin (B and 
D) and euthanized at P4 (A and B) or P8 (C and D). Sections were stained with anti-DDX4 
(green) and anti-MKI67 (red). F-actin was stained with phalloidin to visualize testis cords  
(blue). Quantitation of the number of MKI67+/DDX4+ germ cells from testes treated starting at 
P1 with vehicle or rapamycin and then euthanized at P4 (top) or at P8 (bottom) (E). Scale bar=50 
µm. Asterisks indicate statistical significance (P≤0.01). 
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Figure 4.5 Inhibition of mTOR does not affect Sertoli cell numbers or morphology. (A-B) 
Immunostaining of testis sections from mice treated with vehicle (A) or rapamycin (B) and 
euthanized at P8. Sections were stained with anti-GATA4 (green) and anti-DDX4 (red). F-actin 
is stained with phalloidin (blue) to visualize testis cords. (C) The number of GATA4+ cells per 
cross section of testis cord were quantitated and reported as a fold change. Scale bar=40 µM. 
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Figure 4.6 MTOR activation is required for induction of SOHLH1, SOHLH2, and KIT 
protein. Immunostaining of mice treated with vehicle (A, C, and E) or rapamycin (B, D, and F) 
and euthanized at P4. Sections were stained with anti-SOHLH1 (A and B), anti-SOHLH2 (C and 
D), or anti-KIT (E and F). F-actin was stained with phalloidin (red) to visualize testis cords. 
Scale bar=50 µm. 
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Figure 4.7 Inhibiting mTORC1 activation increases the number of undifferentiated 
spermatogonia. (A, B, D, and E) Immunostaining was performed on testis sections from mice 
treated with vehicle (A and D) or rapamycin (B and E) and euthanized at P8. (A-C) Testis 
sections from CD-1 mice were stained with anti-GFRA1 (green, A and B) and F-actin was 
stained with phalloidin (blue) to visualize testis cords. The number of GFRA1+ germ cells in 
vehicle- and rapamycin-treated testes were quantitated and reported as a fold change (C). (D-F) 
Transgenic Id4-GFP mice were treated with vehicle or rapamycin, and immunostaining was 
performed on testes. Green represents GFP epifluoresence, and sections were labeled with anti-
DDX4 (red). White arrows indicate GFP bright spermatogonia (D and E). The number of GFP 
bright cells were quantitated and represented as a percentage of the DDX4+ cells (F). Scale 
bar=40 µm. Asterisks indicate statistical significance with (P<0.01). 
 
 
 
 
 
 
 
 
 
 
 
 
    
 132 
 
 
 
 
 
 
 
 
SO
HL
H1
 F
-a
cti
n 
!
SO
HL
H2
 F
-a
cti
n 
!
Sohlh1!
Sohlh2!
P1-2 RA!P1-2 Vehicle !
A! B!
D! E!
C!
F!
Fo
ld 
ch
an
ge
!
Fo
ld 
ch
an
ge
!
0!
2!
4!
6!
8!
10!
12!
0!
5!
10!
15!
20!
25!
*!
*!
*!
G! H!
KI
T 
F-
ac
tin
 !
I!
0!
5!
10!
15!
20!
25!
Fo
ld 
ch
an
ge
!
Kit!
Vehicle! RA! RA!Vehicle!
Abundance! Polysomes!
*!
Vehicle! RA! RA!Vehicle!
Abundance! Polysomes!
Vehicle! RA! RA!Vehicle!
Abundance! Polysomes!
    
 133 
Figure 4.8 RA induces expression of SOHLH1 and SOHLH2 protein. (A, B, D, E, G, and H) 
Immunostaining of testis sections from mice treated at P1 with vehicle (A, D, and G) or RA (B, 
E, and H) and euthanized 24h later (at P2). Sections were stained with anti-SOHLH1 (A and B), 
anti-SOHLH2 (C and D), or anti-KIT (G and H) and F-actin was stained with phalloidin (red) to 
visualize testis cords. QRT-PCR was performed on RNA isolated from whole testis lysate of 
mice treated with vehicle or RA, and total Sohlh1, Sohlh2, and Kit mRNA levels were measured 
(left side, C, F, and I). Messenger RNAs were separated by ribosome occupancy, fractions 
containing heavy polysomes were pooled, and qRT-PCR was performed to quantify polysome-
associated Sohlh1 and Sohlh2 (right side, C, F, and I). Scale bar=40 µm. Asterisks indicate 
statistical significance with (P<0.01). 
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Figure 4.9 RA signaling through mTORC1 is required for induction of KIT but not STRA8. 
(A-C) Message abundance for Sohlh1, Sohlh2, and Kit were measured by qRT-PCR using whole 
testis RNA of mice treated with vehicle or rapamycin and then euthanized at P4. Sohlh1, Sohlh2, 
and Kit mRNAs associated with polysomes were pooled, isolated, and quantitated by qRT-PCR. 
(D) Mice were treated daily starting at P1 with vehicle or rapamycin. At P3, mice were given a 
single exogenous injection of RA and euthanized 24h later at P4. (E and F) Immunostaining of 
testis sections of mice treated with vehicle (E) or rapamycin (F) and RA and then euthanized at 
P4. Sections were labeled with KIT (green) and STRA8 (red), F-actin was stained with 
phalloidin (blue) to visualize testis cords. (D) Message abundance for Stra8 in testes from mice 
treated with rapamycin from P1-3 and then euthanized 24h later (P1-4 Rap) and from mice 
treated with rapamycin from P1-3 and then with 1 dose of RA on P3 and euthanized on P4 (P1-4 
Rap +24h RA).Scale bar=40 µm. Asterisks indicate statistical significance with (P<0.01). 
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Figure 4.10 RA signaling through PI3K/AKT/mTOR is required for spermatogonia 
differentiation. Specific mRNAs are inefficiently translated (repressed) in undifferentiated germ 
cells. RA signaling through a kinase (non-genomic) signaling pathway activates the 
PI3K/AKT/mTORC1 signaling network to induce efficient translation of genes (e.g. Kit, Sohlh1, 
and Sohlh2) that are required for differentiation. Rapamycin inhibition of mTORC1 prevents RA 
induced efficient translation, and blocks spermatogonia differentiation.  
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Gene$ Upstream$primer$(5’03’)!! Downstream$primer$(5’03’)!!
Sohlh1&
&
GGGCCAATGAGGATTACAGA!! AAGTTTGCAGCAGCCACAG!!
Sohlh2!! TCTCAGCCACATCACAGAGG!! GGGGACGCGAGTCTTATACA!!
Kit!! CATGGCGTTCCTCGCCT!! GCCCGAAATCGCAAATCTTT!!
Stra8!! TCACAGCCTCAAAGTGGCAGG!! GCAACAGAGTGGAGGAGGAGT!!
B2m!! CCGTGATCTTTCTGGTGCTT!! CGTAGCAGTTCAGTATGTTCG!!!
Table 4.1 QRT-PCR primer sequences. 
!
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Protein Vendor (Catalog number) Dilution 
DDX4 Abcam (ab13480) 1:250 
DDX4 R&D Systems (AF2030) 1:800 
RET Cell Signaling Technology (#3223) 1:200 
STRA8 Abcam (ab49602) 1:3000 
KIT Santa Cruz Biotechnology (sc-1494) 1:1000 
KIT Cell Signaling Technology (3074) 1:1000 
SOHLH1 Alexsandar Rajkovic (Pangas et al., 2006) 1:200 
SOHLH2 Alexsandar Rajkovic (Ballow et al., 2006) 1:200 
c-PARP1 Cell Signaling Technology (#9544) 1:100 
p-RPS6 Cell Signaling Technology (#5364) 1:800 
p-MTOR Cell Signaling Technology (#2880) 1:100 
GFRA1 R&D Systems (AF560) 1:800 
GATA4 Santa Cruz Biotechnology (sc-1237) 1:100 !
Table 4.2 Antibody vendors, catalog numbers, and dilutions 
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CHAPTER V: CONCLUSIONS AND GENERAL DISCUSSION 
 
In the mouse, spermatogenesis begins in the neonatal testis as prospermatogonia reenter 
the cell cycle and become spermatogonia. Some spermatogonia differentiate in response to RA at 
approximately P3-4, while others remain undifferentiated to become SSCs. Little is known about 
the molecular mechanisms and cellular processes that direct spermatogonial differentiation 
downstream of RA. The reason for this deficiency is two-fold. First, the majority of researchers 
in the field are currently focused on studying SSCs, and therefore comparatively little attention 
has been paid to understanding the mechanisms of spermatogonial differentiation. Second, few 
genes change their mRNA abundance as SSCs transition to progenitor spermatogonia or in 
response to RA during spermatogonial differentiation [153, 154], which means that few clues are 
available for identification of important pathways and processes to study. Our lab previously 
identified mRNAs, from over 3,000 genes, that become more efficiently translated during the 
period of spermatogonial differentiation from P1-4 [158]. Several of these genes encode key 
determinants of spermatogonial differentiation, and the expression of encoded proteins increase 
dramatically in response to RA. Chapters II-IV of this dissertation contain my first-author 
published manuscripts that document the molecular and cellular changes in spermatogonia 
downstream of RA signaling. These studies revealed a novel non-genomic mechanism by which 
RA directs gene expression by activating the PI3K-AKT-mTORC1 signaling network. This work 
has significantly advanced our understanding of the processes that direct spermatogonial 
differentiation downstream of RA. 
In the adult mouse, periodic RA surges signal progenitor spermatogonia to differentiate at 
stage VIII of the seminiferous epithelial cycle [313]. However, if all spermatogonia 
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differentiated in response to RA, the SSC pool would be lost and spermatogenesis would not be 
sustained. Therefore, mechanisms must exist to “protect” SSCs from RA exposure, especially in 
stage VII and VIII tubule segments where RA levels are highest. It is possible that a specific 
niche protects SSCs from RA, akin to how fetal prospermatogonia are protected from RA by 
CYP26B1 [54, 56, 57]. Alternatively, SSCs may avoid the RA signal by not expressing the 
correct RAR subtype(s). We attempted to test this by injecting neonatal mice with RA at P0, 
before prospermatogonia that will become SSCs migrate to the periphery and associate with their 
cognate niches. Following exposure at P0, adult spermatogenesis was synchronized but 
otherwise appeared normal (our unpublished results). In addition, only 60% of P1-2 
prospermatogonia become STRA8+ following treatment with RA in vivo. Interestingly, in 
Chapter II we report that only 60% of spermatogonia become BrdU+ 24 h after treatment with 
RA. While these studies are ongoing, this evidence suggests that a subset of prospermatogonia is 
intrinsically programmed to avoid responding to RA.  
Stem cells are generally slow-cycling cells that proliferate infrequently and provide little 
direct contribution to the physiological function of their resident tissues. Stem cell maintenance 
is a complex process that requires coordination between many different factors, the majority of 
which are currently undefined. Metabolism and oxygen availability are emerging as key 
modulators of stem cell differentiation. Most stem cells reside in avascular niches, characterized 
by relatively low oxygen concentrations (reviewed by [314]). In addition, many types of stem 
cells disproportionately rely on glycolysis rather than oxidative phosphorylation (OXPHOS) for 
the production of ATP [315-317]. The low level of OXPHOS is often accompanied by 
underdeveloped mitochondria, which are small, round, and contain few cristae as compared to 
differentiated cells (reviewed by [318, 319]). Collectively, these features have been suggested to 
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help prevent cellular differentiation [320].  Reliance on glycolysis may be a consequence of 
hypoxia, as hematopoietic stem cells (HSCs) can switch to OXPHOS when cultured in 
atmospheric normoxic conditions (21% O2) [321]. However, senescence is significantly 
increased when HSCs are cultured under these conditions. Furthermore, mESCs that are cultured 
in atmospheric hypoxia (1-5% O2) are more resistant to spontaneous differentiation than those 
cultured in 21% O2 [322]. This supports the hypothesis that lowered O2 levels promote stem cell 
self-renewal. A plausible explanation for stem cells’ preference for a hypoxic environment is that 
cellular damage and DNA mutation load inflicted by a highly oxidative environment (which 
produces reactive oxygen species, or ROS), as with a need for increased energy production seen 
in highly proliferative cell types, would be reduced. Accumulation of these defects in the stem 
cell pool would be predicted to accelerate tissue aging and lead to premature loss of tissue 
function. Furthermore, progenitor daughter cells proliferate and differentiate to acquire new 
lineage-specific functions. In order to support these functions, cells often modify their 
metabolism to support increased protein biosynthesis, trafficking, degradation, and secretion 
(reviewed by [318]). Generally, stem cells do not participate in these activities, possibly to avoid 
the potential for cellular damage and associated DNA mutations. 
It is reasonable to predict that such an increase in cellular activity would be accompanied 
by changes in organelle structure and function. Indeed, increased mitochondrial division 
(fission), maturation, and increased reliance on OXPHOS are common features of stem cell 
differentiation (reviewed by [323]). Ultrastructure studies of the developing testis suggest that 
similar changes accompany spermatogonial proliferation and differentiation [219-221]. We 
found that RA administration increased the size of the Golgi apparatus and stimulated 
mitochondrial biogenesis, as evidenced by an increase in the presence of numerous shelf-like 
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cristae. These observations raise several important questions. First, does maturation of organelles 
occur in preparation for differentiation, or as a consequence of increased energy demand of the 
cell as it differentiates? Second, does RA signaling directly induce maturation of Golgi and 
mitochondria, or is it an indirect consequence of increased energy demand from the cell as RA 
stimulates proliferation and differentiation? Third, do the morphological changes in Golgi and 
mitochondria that accompany differentiation reflect significant changes in function? 
Understanding these changes will significantly advance our understanding of the molecular 
processes that either direct or accompany spermatogonial differentiation and also provide 
valuable insight into the biology of SSCs. 
The central dogma of molecular biology states that information flows from DNA to RNA 
to protein [324]. However, this process is subject to a variety of regulatory mechanisms at each 
step. Some genes are regulated primarily at the level of transcription, as exemplified by the 
expression of genes encoding heat shock proteins during cellular stress (reviewed by [325]). 
Other genes rely predominantly on post-transcriptional regulation, including the protamine genes 
Prm1 and Prm2, which are transcribed in spermatocytes but not translated until elongating 
spermatids are formed during spermiogenesis (reviewed by [326]). During neonatal testis 
development, few genes increase their mRNA abundance [154], but we discovered a dramatic 
increase in translational efficiency for a large number of mRNAs as spermatogonia begin to 
differentiate [158]. These findings suggest that changes in translational efficiency may provide a 
more accurate predictor of the proteome than changes in mRNA levels alone [258]. 
Translation is the most energy-consuming cellular process (reviewed by [327]), and its 
regulation occurs primarily at the initiation step. This allows expression of required proteins 
while reducing the accumulation of unwanted proteins and preventing the associated energy 
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expenditure. Messenger RNAs that encode housekeeping genes tend to readily recruit multiple 
ribosomes and are generally efficiently translated. In contrast, mRNAs that encode proteins for 
specialized cellular functions are often subject to more stringent control, and may not be 
efficiently recruited to ribosomes unless directed by some stimulus (reviewed by [183]). Our 
results demonstrate that Kit, Sohlh1, and Sohlh2 mRNAs are examples of such mRNAs, and 
undergo significant translational control during spermatogonial development. Although readily 
detectable in undifferentiated spermatogonia, they are not translated efficiently. RA treatment 
increases the translational efficiency of these mRNAs by mobilizing them into heavy polysomes, 
which occurs without accompanying increases in mRNA abundance. A number of different 
mechanisms may account for these changes in translational efficiency, and the Geyer laboratory 
will explore these in the future. Possible mechanisms include RA-induced transcription of 
different RNA isoforms through utilization of alternative transcription start sites or alternative 
splicing. Also, RA signaling may indirectly increase the stability of these mRNAs. However, 
results from preliminary studies done in our lab indicate alternative spicing or mRNA stability 
are unlikely mechanisms (Velte and Geyer, unpublished results). Activation of kinase signaling 
pathways is another way that external stimuli can exert post-transcriptional control of gene 
expression, by phosphorylating components of the translational machinery. 
There are many different kinase-signaling networks, and they are essential for a vast 
array of cellular processes. The PI3K-AKT-mTOR network is a key regulator of cellular activity, 
and can exert different effects depending on the cell type and context. As an example, activation 
of PI3K-AKT is required for mESC self-renewal [262], but activation of PI3K-AKT-mTOR is 
also required for HSC differentiation (reviewed by [328]). Similar to its role in mESCs, 
activation of PI3K-AKT by GDNF is required for maintenance of the SSCs pool, and results in 
    
 145 
transcription of factors essential for self-renewal [111]. However, PI3K/AKT signaling in SSCs 
does not activate mTOR; recent results indicate mTORC1 activity must be suppressed in SSCs 
[187]. The conditional deletion of the mTORC1 inhibitor Tsc2 in prospermatogonia resulted in 
aberrant mTORC1 activation in, and progressive depletion of, SSCs. Although mTORC1 
activation is incompatible with SSC maintenance, its role in spermatogonial differentiation was 
unknown, which is what motivated us to pursue the studies outlined in chapter 4. These results 
show that RA signals through PI3K-AKT-mTORC1 to direct the efficient translation of Kit, 
Sohlh1, and Sohlh2 and begin the process of spermatogonial differentiation. Thus, PI3K/AKT 
signaling is activated downstream of multiple inputs (RA and GDNF) in spermatogonia, and 
directs two apparently opposing cellular responses. It is plausible that mTORC1 may function as 
the integral downstream molecular switch separating these processes.  
A primary role of RA is to direct changes in gene expression (reviewed by [195]). 
Traditionally, RA is believed to accomplish this by directing changes in transcription. However, 
recent work challenges this mechanism of action, and ascribes a non-genomic regulation of gene 
expression role to RA. Our results support this non-genomic function in spermatogonia, and 
indicate that RA activation of the PI3K-AKT-mTOR kinase signaling network induces the 
efficient translation of Kit, Sohlh1, and Sohlh2 mRNAs. However, inhibiting each component of 
this pathway did not appreciably alter RA-dependent expression of Stra8, a gene that is 
transcriptionally activated by RA. These data support a model whereby RA acts through two 
separate pathways to modulate gene expression in spermatogonia.    
RA has an established role in directing spermatogonial differentiation. Our studies, as 
well as those from other laboratories, established that sustained exposure to RA is required to 
maintain spermatogonial differentiation in the neonatal testis [96, 97]. Our results suggest that 
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depletion of RA in the neonatal testes, such as after upregulation of CYP26A1, results in the 
reversion of differentiated spermatogonia to an apparently undifferentiated state. In the adult, RA 
signaling is spatially restricted to stages VII-VIII of the seminiferous cycle, where it initiates 
spermatogonial differentiation (Type A1). However, the subsequent differentiation divisions 
(Type A2-Type B) occur in low levels of RA [151]. It is possible that spermatogonial 
differentiation progresses because RA activates PI3K-AKT-mTOR to stimulate KIT expression 
and that KIT then binds to its ligand (KITL), which is produced by adjacent Sertoli cells, to 
sustain PI3K-AKT-mTOR activity [233, 279]. Thus, activation of KIT by KITL may maintain 
spermatogonial differentiation in the stages where RA levels are low, although this remains to be 
tested experimentally.  
By P1, nearly all spermatogonia have reentered the cell cycle and migrated to the 
periphery of the seminiferous cords [68]. The results from chapter 2 reveal that P1 
prospermatogonia are competent to differentiate in response to RA, but are apparently awaiting 
the signal, which arrives beginning at P3-4. Under normal conditions, RA signaling initiates 
gradually and in discrete areas of the seminiferous cords. This is evident from the observation 
that there are isolated groups of STRA8+ spermatogonia within a cord, while an adjacent cord 
contains STRA8- spermatogonia [91]. If RA levels are reduced, such as by treatment with WIN 
18,446 or by prolonged feeding a VAD diet, spermatogonial development is blocked at the Aal-
A1 transition [114, 115, 117, 246, 329]. Spermatogenesis initiates upon re-administration of RA, 
with large areas of seminiferous tubules in the same stage of the spermatogenic cycle [114, 330, 
332].  
Treatment of neonatal mice at P1 or P2 with a single dose of RA also leads to 
regionalized synchronization of spermatogenesis in the adult [97, 206]. A putative mechanism 
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for this effect is that RA stimulates rapid induction of CYP26A1, which subsequently degrades 
both exogenous and endogenous RA. High levels of RA lead to transcriptional activation of 
Cyp26a1; its mRNA levels peaks within 12 h [97], and decline by 24 h after treatment [96]. This 
rapid reduction in Cyp26a1 mRNA abundance suggests that the majority of RA has been 
degraded and is no longer inducing transcription. Therefore, spermatogonia are likely exposed to 
exogenous RA for a relatively short period of time. Induction of CYP26A1 may reduce both 
exogenous and endogenous RA, leading to an arrest of spermatogonial differentiation. 
Spermatogonia collectively reinitiate differentiation 2-3 days post RA exposure, and as a result, 
spermatogenesis remains partially synchronized, even to adulthood. Interestingly, 
synchronization is significantly reduced when RA is administered on P6 and is absent if 
administered on or after P8 [97, 206]. Spermatogonial resistance to synchronization correlates 
with the temporal emergence of preleptotene spermatocytes. Results from the Griswold 
laboratory suggest that preleptotene spermatocytes alter the microenvironment within the 
seminiferous cords and possibly by inhibiting spermatogonial differentiation following RA 
administration at P8 [206]. However, this theory does not account for the dramatic reduction in 
synchronization observed when P6 mice were administered exogenous RA. As discussed above, 
activation of KIT/KITL activates PI3K-AKT-mTOR [233], which may function to maintain 
spermatogonial differentiation when RA levels are low. We postulate that the short period of RA 
exposure following exogenous administration at P1 or P2 does not result in stable KIT/KITL 
signaling, which would be predicted to maintain the differentiated state once RA levels fall. It is 
possible that differentiating spermatogonia present after P6 have “established” KIT/KITL 
signaling and are no longer dependent upon RA [97, 206].     
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As discussed above, a single dose of exogenous RA initiates spermatogonial 
differentiation in neonatal testes, as shown by expression of KIT and STRA8. However, 48 h 
later KIT and STRA8 are no longer detectable, and spermatogonia appear to transiently arrest 
their differentiation and revert to an undifferentiated state. This is in stark contrast to steady state 
spermatogenesis in the adult, where a transient RA surge signals spermatogonial differentiation 
and expression of KIT through subsequent cell divisions and epithelial stages until meiosis is 
initiated in preleptotene spermatocytes 8.6 days later. Aldh1a1-3-null mice, which lack the 
ALDH1A1-3 enzymes that catalyze conversion of retinaldehyde to RA in Sertoli cells, required 
treatment with exogenous RA to initiate spermatogonial differentiation [130]. These mice exhibit 
a testicular phenotype similar to VAD mice, with the seminiferous cords containing only Sertoli 
cells and undifferentiated spermatogonia. However, spermatogenesis is restored and 
spermatogonia differentiate normally if these mice are administered a single dose of RA. 
Currently, it is unknown why neonatal spermatogonia do not complete differentiation after 
administration of a single dose of RA at P1 or P2 [96, 97]. Perhaps neonatal spermatogonia 
require prolonged exposure to RA to fully commit to differentiate as compared to those in 
juvenile and adult testes. It is worth noting that in the adult, RA signals during stages VII-VIII of 
the seminiferous cycle that collectively take approximately 41 h to complete [84]. The half-life 
of RA in vivo is approximately 1 h, and therefore our injected RA is likely gone 24 h after 
administration [332]. The requirement for prolonged RA exposure to complete spermatogonial 
differentiation might be addressed by administration of multiple doses of RA or by co-
administration of RA and the CYP26 inhibitor ketoconazole. 
An alternative explanation for why P1 spermatogonia do not commit to differentiation 
following administration of a single dose of RA is that the somatic environment is unable to 
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sustain spermatogonial differentiation at P1-2. As discussed above, we envision that KIT 
signaling through PI3K-AKT-mTOR maintains spermatogonial differentiation in low levels of 
RA. Assuming this theory is correct, activation of KIT is dependent upon expression of KITL by 
adjacent Sertoli cells. If RA does not induce KITL, then KIT would remain inactive and 
spermatogonial differentiation would be arrested. Maintenance of spermatogonial differentiation 
by KIT/KITL signaling allows RA to exert temporal control over events that occur during stages 
VII-VIII (e.g. spermatogonial differentiation, meiotic entry, and spermiation) [130]. If prolonged 
RA exposure was required throughout all stages of differentiation, it is hard to imagine how the 
undifferentiated progenitor population would be maintained. If the transit-amplifying progenitors 
differentiated without first proliferating, this would lead to a dramatic reduction in sperm 
production. Characterization of the mechanisms that maintain spermatogonial differentiation in 
the epithelial stages where RA is low or absent will significantly advance our understanding of 
spermatogonial development.  
The PI3K-AKT-mTOR kinase-signaling network is emerging as an important 
determinant of spermatogonial cell fate. In the past five years, only 15 articles have been 
published on PI3K, AKT, or mTOR in the context of SSC maintenance or spermatogonial 
differentiation. Of these, 9 have been published within the last year, which indicates that 
scientists are beginning to recognize the importance of this signaling network in SSC 
maintenance and spermatogonial differentiation. Our studies demonstrate that RA signals 
through dual pathways to regulate gene expression in spermatogonia. These pathways likely 
regulate distinct cellular functions, and their identification represents a significant advance in our 
understanding of spermatogonial biology and of the molecular processes that control 
spermatogonial fate decisions. Perhaps most important are the new avenues for future study of 
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spermatogonia biology that are opened by the discovery of alternative pathways by which RA 
controls gene expression in spermatogonia. 
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